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Abstract
Because tuberculosis (TB) is a public health threat that continues to elude elimination in
the United States, there is a need to identify contributing factors that may have
implications for targeted control measures. Molecular studies of genetic clustering are
crucial for pinpointing these contributing factors. It is for this reason this study was
conducted. This was a non-experimental, cross-sectional population-based molecular
epidemiological study of TB in SC from 2005 to 2011. Its purpose was to estimate the
proportion of TB that may be due to recently acquired infection and to determine the risk
factors associated with the genetic clustering of identical M. tuberculosis isolates from
TB patients in South Carolina from 2005-2011. The analysis sample included 627
confirmed pulmonary and/or pleural cases of TB, for which complete data on all
covariates and a valid genotype were available. The results strongly suggested that about
50% of TB in South Carolina is recently transmitted. The study also revealed that being
born in the United States and Black race were independently and significantly associated
with being part of a TB genotype cluster. The key messages of this study were as follows:
a substantial portion of TB in South Carolina is due to recent transmission, not
reactivation or importation, and transmission of TB in South Carolina occurs in groups
often defined by American birth and Black race. These important findings indicate that
most TB in South Carolina is preventable and that enhanced TB control efforts should be
explored. The implication for positive social change is that employing targeted contact
investigation informed by these findings could lead to decreased disease transmission.
Future studies should explore pilot programs that investigate alternatives to the traditional
TB contact investigation.
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Chapter 1: Introduction to the Study
Introduction
The global and domestic impact of tuberculosis (TB) disease is substantial.
According to recent estimates, the current global incidence is nearly 9.6 million people
(WHO, 2016). While global mortality has decreased in the last decades, it remains a
staggering 1.5 million deaths in 2014 alone. This figure is unacceptable given that most
of these deaths are preventable (WHO, 2016). The United States is considered a country
with comparatively low incidence, at 3.2 cases per 100,000 persons. Despite this low
case rate and the U .S. TB program, which is often regarded as the gold standard for
control and prevention, between 500 and 600 people die every year from TB in the
United States. Particularly concerning are the considerable racial and ethnic disparities
extant in TB disease impact across the United States. In 2014, the rate of TB disease in
Blacks was 5.8 cases per 100,000 persons, which is over 7 times higher than the rate of
TB disease in White, non-Hispanics (0.8 cases per 100,000 persons). Similarly, in
Hispanics/Latinos, the rate of TB disease was 5.3 cases per 100,000 persons–again, over
7 times higher than the rate of TB among White, non-Hispanics (CDC, 2016).
The Division of Tuberculosis Elimination (DTBE) at the CDC has, as its
primary goal, the elimination of TB in the United States, where elimination is defined as
≤1 case/million persons (CDC, 2013). To this end, continuing research in U. S.
populations affected by TB is imperative. Molecular studies of genotype clustering are
important for identifying risk factors that contribute to the ongoing transmission of TB
in the U.S.. Genotyping may facilitate quicker (a) confirmation of known contacts, (b)
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detection of unknown contacts, or (c) revelation of transmission environments
(Malakmadze, 2006,Yeo, 2006). This has been exemplified by clustering studies that
have elucidated risk factors, which, in turn, serve TB prevention efforts by informing
TB control programs where to target their limited resources (Miller, 2002; Suffys,
1997).. The goal of this research was to estimate the proportion of South Carolina TB
may be due to recently acquired infection, and determine the risk factors associated with
the genetic clustering of identical M. tuberculosis. This study has implications for social
change including to further the TB elimination goal by elucidating risk factors for
ongoing transmission in South Carolina, thereby informing the South Carolina TB
Control Program and potentially other states’ control efforts, particularly states with
populations and public health resources that compare favorably to those of South
Carolina.
This chapter will review the problem and purpose of the study, describe the
research questions, assumptions, limitations, commonly used terms, and describe the
conceptual framework of the study.
Background
Because traditional contact investigation often fails to reveal source cases,
molecular epidemiology is an important adjunct to modern TB control programs (Cacho
Calvo, 2005; Ellis, 2002). While several studies employing TB genotyping have been
conducted, many have focused on urban areas such as Los Angeles, Vancouver, New
York, and San Francisco (Barnes, 1997; Hernandez-Gardduno, 2002; Driver, 2006 &
Cattamanchi, 2006, respectively) or European populations such as England, Spain, and
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Italy (Love, 1998; Cacho Calvo, 2005; Francetti, 2010). The statewide studies in the
U.S. have been conducted primarily in the northeast: Massachuttes, New York, and
Maryland (Miller, 2002; Ellis, 2002; & Torgersen, 2006). The only study from the
southeast U.S. was in Alabama on data from 17 years ago, 1994-2000 (Kempf, 2005).
My study addresses this gap in the literature by characterizing the molecular
epidmiology of TB in one state in the southeast United States, that of South Carolina. It
provided a unique opportunity to examine both natively acquired and foreign-born
tuberculosis, increasingly merging urban and rural environments, and conspicous,
unaddressed racial disparities in TB disease (MMWR, 2006; MMWR, 2011). Because
TB continues to elude elimination in the U.S., there is a need to identify contributing
factors that may have implications for targeted control measures. Molecular studies of
clustering are crucial for pinpointing these factors. While incident cases of TB have
decreased in South Carolina over the previous 8 years, going from 261 cases reported in
2005 to 140 cases reported in 2011 (South Carolina DHEC, 2014), South Carolina still
had the 15th highest case rate in the U.S. (2011) with 3 cases per 100,000 people (CDC,
2013). Of further concern is that the epidemiology of TB in South Carolina has long
been characterized by extreme racial and ethnic disparities. From 2009-2014, 56.4% of
South Carolina’s TB cases were Black, 11.9% Hispanic or Latino, and 11.1% Asian,
while Blacks, Hispanics/Latinos, and Asians comprised only 27.9, 5.1, and 1.3% of the
state’s population, respectively (CDC, 2016). Adding to the complexity of the race issue
is the dramatic disparity in AIDS diagnoses in South Carolina, with 69% of new AIDS
cases in 2013 occurring in Blacks (CDC, 2015). Because TB progresses from infection
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to disease more often and more quickly in HIV patients, it is more difficult to treat and
more likely to lead to death in persons co-infected with AIDS, illuminating and
targeting any interacting racial, lifestyle, and economic disparities associated with these
comorbidities should be a priority of public health. Approaches that could be initiated
that simultaneously address TB and HIV co-infection should be investigated.
Another area of increasing concern in the last decade is the emergence and
spread of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDRTB), both of which pose a global threat to health, economic development, and national
security, undermining the significant progress made globally and domestically to
accomplish TB elimination (United States Government Global Tuberculosis Strategy,
2015). South Carolina has been affected by this, having had nine cases of TB between
2005 and 2011 that were resistant to at least one TB treatment drug, only one of which
was MDR-TB. Fortunately, South Carolina has had no cases of XDR-TB to date. My
study population did not contain enough drug-resistant TB to examine drug resistance
as a covariate. However, the emergence of MDR-TB worldwide and in the U.S.
underscores the need for comprehensive genotyping in even low-prevalence
communities such as South Carolina. Not because genotyping is necessary to
distinguish drug resistance (other types of laboratory tests can determine drug resistance
without the need for a full genotype) but because genotyping facilitates identification of
chains of transmission. When and if cases of MDR-TB and XDR-TB occur, in order to
target inventions it will be crucial for TB control programs to understand whether these
cases were entirely imported or imported and then locally transmitted.
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Statement of Problem
TB disease is a current, relevant, and immediate public health threat of global
concern. Households with at least one income-producing member sick with TB but
getting treated typically loses 3–4 months’ work and about 2% of income; an untreated
person with TB may lose as much as a full year of work. In the countries with the
highest TB prevalence, which often happen to be the poorest countries, lost productivity
due to TB may translate to 4–7% of the gross domestic product (GDP) (U.S. DOS,
2009). In the U.S., despite sustained efforts to eliminate TB and trends reflecting
declining incidence in the last decade, more than 9,400 new cases were diagnosed in
2014 (CDC, 2015). Further, TB is not just a disease of adults, even in our wealthy
modern society; children are still infected with 486 people less than 15 years old
diagnosed in the U.S. in 2012 (CDC, 2013). TB infection in children is especially
troubling because it represents new transmission (as opposed to latent disease), and thus
indicates a conspicuous failure in U.S. TB control efforts. Moreover, as mentioned
earlier, U.S. Blacks are over 7 times more likely to be diagnosed with TB than Whites
are. Many reasons have been postulated for this disproportionately high rate of TB
among Blacks compared to Whites, including SES, comorbidities, and genetics but it
has yet to be entirely explained by any of those variables. SES may explain much of this
disparity, but the relationship is complex, thus the solution will likely also be complex
(Cantwell, 1998).
In order for public health to address TB’s impact on children, minority
populations, and income and productivity, the risk factors associated with transmission
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have to be clearly defined. Cacho-Calvo and co-authors (2005) observed that public
health contact tracers found epidemiological links in only 85 (37.4%) of the 231 cases
belonging to a genotype cluster, indicating that traditional contact investigation misses
many cases (). The findings of the Cacho-Calvo study underscore how important it is
that genotype cluster investigations accompany traditional contact investigations
(Cacho-Calvo, 2005). A Canadian study from 2006 had similar findings and revealed
how essential TB genotyping in children can be. Although sputum specimens can be
extremely difficult to obtain in children, Yeo et al. (2006) were able to obtain specimens
and successfully genotype M. tuberculosis in 38 pediatric TB cases. From genotyping,
investigators identified 14 possible source cases. In contrast, they were only able to
identify one possible source case from traditional contact investigation alone (Yeo,
2006).
Studies that have examined predictors of TB genotype clustering have had
some success in clarifying factors associated with TB transmission. Among confirmed
TB cases, three characteristics were found by multiple studies to be associated with
being part of a TB genotype cluster: history of incarceration, history of alcohol abuse,
and history of illicit drug abuse (Barnes, 1997; Ellis, 2002; Kempf, 2005; Cattamanchi,
2006; Driver, 2006). Not coincidently, these are also characteristics associated with
crowded, marginalized populations that may have limited access to healthcare. My
research examined these factors and others to determine those that were significantly
associated with being a part of an identical TB genotype cluster of two or more cases, in
hopes of clarifying TB transmission dynamics in South Carolina.
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Purpose of Study
The two goals of this research were to estimate the rate of recent TB transmission
and to determine the risk factors associated with the genetic clustering of identical M.
tuberculosis isolates from TB patients in South Carolina from 2005-2011 by using a
multivariable logistic regression technique to model risk factors for the binary outcome of
being part of a TB genotype cluster, yes or no.
Research Questions and Hypotheses
I developed the following research questions in order to determine the risk
factors for TB genotype clustering, and to estimate the rate of recent transmission of TB
in South Carolina from 2005-2011. The literature suggests that, based on population-based
studies, TB isolates sharing identical genotype profiles (also known as clustered isolates)
are likely from patients with recently acquired infection (Driver, 2006; Ellis, 2002).
Therefore, the answer to Research Question 1 would approximate what proportion of TB in
South Carolina may have been due to recent transmission.
Research Question 1:
a) Using the mycobacterial interspersed repetitive unit (MIRU) genotyping
method, and spoligotyping, for cluster classification of tuberculosis cases in
South Carolina, I estimated the proportion of TB cases that were genotyped
clustered versus unique (hence forward referred to as “clustered versus
singleton”)?
b) I estimated the proportion of South Carolina TB cases that may be due to
recently acquired infection. The following logic was applied:
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I. For genotype clusters of only two cases: One case of the cluster was
assumed to be a source case. One case of the cluster was assumed to
be the recently infected case.
II. For genotype clusters of two or more cases: One case of the cluster was
assumed to be the source case. All other matches in the cluster were
assumed to be due to recent transmission.
Thus, C - 1, were counted as recently transmitted cases, where C was the
number of identical isolates in the cluster. This method is based on a recent
transmission index that has been used in prior studies, RTIn-1 = (nc - c)/n, in which n is
the total number of the studied cases, nc is the total number of cases in a cluster (size 2
or greater) and c is the number of genotypes represented by at least two cases. Based on
this index, patients in a cluster are considered recent transmission and non-cluster cases
considered reactivation. The n−1 approach denies the possibility of more than one
source case. This index has also been referred to as the “n-1 method” (Reza Allahyar
Torkaman, 2014; Ricks, 2009).
Research Question 2: I determined the risk factors of genotype clustering among
incident South Carolina TB cases from 2005 to 2011 considering the following
hypotheses:
H0

There is no relationship between being US-born and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between being US-born and being part of
a TB genotype cluster when controlling for other significant covariates.
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Ha2

There is a negative relationship between being US-born and being part of
a TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between age and being part of a TB genotype
cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between age and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between age and being part of a TB
genotype cluster when controlling for other significant covariates.

H0

There is no relationship between being male and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between being male and being part of a
TB genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between being male and being part of a
TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between black race and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between black race and being part of a
TB genotype cluster when controlling for other significant covariates.
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Ha2

There is a negative relationship between black race and being part of a
TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between hispanic ethnicity and being part of a
TB genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between hispanic ethnicity and being part
of a TB genotype cluster when controlling for other significant
covariates.

Ha2

There is a negative relationship between hispanic ethnicity and being
part of a TB genotype cluster when controlling for other significant
covariates.

H0

There is no relationship between residence in a correctional facility at the
time of diagnosis and being part of a TB genotype cluster when
controlling for other significant covariates.

Ha1

There is a positive relationship between residence in a correctional
facility at the time of diagnosis and being part of a TB genotype cluster
when controlling for other significant covariates.

Ha2

There is a negative relationship between residence in a correctional
facility at the time of diagnosis and being part of a TB genotype cluster
when controlling for other significant covariates.
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H0

There is no relationship between homelessness within the past year and
being part of a TB genotype cluster when controlling for other
significant covariates.

Ha1

There is a positive relationship between homelessness within the past
year and being part of a TB genotype cluster when controlling for other
significant covariates.

Ha2

There is a negative relationship between homelessness within the past
year and being part of a TB genotype cluster when controlling for other
significant covariates.

H0

There is no relationship between being HIV positive and being part of a
TB genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between being HIV positive and being
part of a TB genotype cluster when controlling for other significant
covariates.

Ha2

There is a negative relationship between being HIV positive and being
part of a TB genotype cluster when controlling for other significant
covariates.

H0

There is no relationship between alcohol abuse and being part of a TB
genotype cluster when controlling for other significant covariates.
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Ha1

There is a positive relationship between alcohol abuse and being part of a
TB genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between alcohol abuse and being part of
a TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between illicit drug use and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between illicit drug use and being part of
a TB genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between illicit drug use and being part of
a TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between injection drug use and being part of a
TB genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between injection drug use and being part
of a TB genotype cluster when controlling for other significant
covariates.

Ha2

There is a negative relationship between injection drug use and being
part of a TB genotype cluster when controlling for other significant
covariates.
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H0

There is no relationship between substance abuse and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between substance abuse and being part
of a TB genotype cluster when controlling for other significant
covariates.

Ha2

There is a negative relationship between substance abuse and being part
of a TB genotype cluster when controlling for other significant
covariates.

H0

There is no relationship between having prior TB disease and being part
of a TB genotype cluster when controlling for other significant
covariates.

Ha1

There is a positive relationship between having prior TB disease and
being part of a TB genotype cluster when controlling for other
significant covariates.

Ha2

There is a negative relationship between prior TB disease and being part
of a TB genotype cluster when controlling for other significant
covariates.

The dependent variable of interest for this study was being part of an
identical TB genotype cluster of two or more cases. The primary independent variables
of interest for this study (or potential risk factors) were as follows:
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being US-born, being younger, being male, being Black, history of homelessness,
history of incarceration, history of alcohol abuse, history of illicit drug abuse, history of
non-injection drug use, history of injection drug use, history of substance abuse (alcohol
and all drug abuse combined), being HIV positive, and prior TB disease.
Based on previous research, it was hypothesized that having the following risk
factors could independently predict being part of a TB genotype cluster: a history of
incarceration, born in the United States, younger age, being male, being Black, being of
younger age, history of homelessness, HIV positive, history of alcohol abuse, and a
history of drug use (Barnes, 1997; Ellis, 2002; Kempf, 2005; Cattamanchi, 2006;
Driver, 2006; Moonan, 2012).
Nature of Study
This was a nonexperimental, cross-sectional, population-based molecular
epidemiological study of TB in South Carolina from 2005 to 2011. All data, including
the TB genotype results, were secondary data. South Carolina DHEC staff originally
collected all patient information and clinical specimens. The genotyping results came
from TB case’s isolates that were sent to a laboratory in Michigan that is under contract
with the CDC to provide genotyping services to TB control programs in the US.
Culture-confirmed cases of tuberculosis in South Carolina isolates' DNA patterns were
analyzed using two polymerase-chain reaction (PCR) methods: MIRU and
spoligotyping. Isolates considered genetically identical by both of these methods were
be defined as clustered—the outcome (dependent) variable of interest for this study.
Risk factors associated with being clustered were first examined individually in a
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bivariate model (one independent variable and the dependent variable), then in a
multivariable logistic model using a stepwise model building approach. The criteria for
inclusion in the multivariable regression model was a p-value of < 0.10 and the criteria
for inclusion in the final multivariable model was a p-value of < 0.05. All analyses were
conducted using SAS 9.3.
Furthermore, clustered cases have traditionally been considered an indication of
recent transmission (Driver, 2006, Ellis, 2002). This population-based, cross-sectional
study examined the proportion of South Carolina tuberculosis that may be due to recent
transmission, and discusses the implications of this for the South Carolina TB Control
Program. The research population consisted of all incident cases of pulmonary and/or
pleural, culture-confirmed TB in South Carolina from 2005 to 2011. Thorough contact
investigations and directly observed therapy (DOT) were the standard of care for all
cases of TB in South Carolina. During these processes, extensive case follow-up and
data collection were performed by the staff of the South Carolina TB Control Program.
All patients included in this study were reported to the CDC national case registry via
the report of a verified case of tuberculosis ([RVCT], CDC DTBE, 2009 ). This form
included 49 variables on patient demographics, laboratory test results, drug
suceptiblities, clinical background, clinical outcomes, and risk behavior. (A copy of this
form is included as Appendix A.) All clincial information, such as laboratory test
results, drug suceptabilities, clinical background and outcomes, were reported by the TB
nurse and verified by the TB consulting physician. Information on patient demographics
and risk behavior was primarily self-reported by the patient. History of homelessness
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was self-reported except in circumstances where the case was identified or treated in a
homeless shelter. The TB nurse then marked this question affirmative.
Definition of Terms
The following section defines terms used throughout the study. Some terms are
discussed further in the literature review.
1. Acid-fast bacilli (AFB): those microorganisms that when stained retain color
even after they have been washed in an acid solution, and may be detected under
a microscope in a stained smear.
2. Active TB disease: an illness, caused by bacteria called M. tuberculosis, in which
bacteria are multiplying and attacking parts of the body, usually the lungs. A
person with active TB disease is able to spread disease to others if the TB
bacteria are active in the lungs or throat. The symptoms of active TB disease
may include weakness, weight loss, fever, no appetite, chills, sweating at night,
bad cough, pain in the chest, and coughing up blood.
3. AIDS-defining condition: is the list of diseases published by the CDC that are
associated with AIDS, and used worldwide as a guideline for AIDS diagnosis.
According to the CDC definition, a patient has AIDS if he or she is infected with
HIV and has either:
•

CD4+ T-cell count below 200 cells/µL

•

a CD4+ T-cell percentage of total lymphocytes of less than 15%

•

or one of the defining illnesses.
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4. Concentric circle method: a method of classifying and screening contacts in
order of intensity of exposure and risk of being infected. Contacts with the most
exposure or highest risk of infection are screened first.
5. Congregate setting: a setting in which a group of usually unrelated persons live
in close physical proximity. These settings may include hospitals, long-term care
facilities, assisted living facilities, prison, jails, or homeless shelters.
6. Contact investigation (may be referred to as contact tracing): a procedure for
interviewing a person who has TB disease to determine who this person may
have exposed to TB. Then those people who may have been exposed are tested
for latent TB infection (LTBI) and TB disease.
7. Contacts: people exposed to someone with infectious TB disease, usually family
members, roommates, close friends, and sometimes coworkers, classmates,
‘drinking buddies’, illicit drug use companions, and others.
8. Directly observed therapy (DOT): a component of TB case management that
helps to ensure that patients adhere to treatment, where the health care worker or
another designated individual administers and watches the patient swallow every
dose of the prescribed drugs.
9. Drug-resistant TB: TB caused by organisms that are unable to grow in the
presence of a particular drug; TB that is resistant to at least one first-line antituberculosis drug.
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10. Ethambutol (EMB): a drug used to treat TB disease; may cause vision problems.
Ethambutol should be used cautiously in children who are too young to be
monitored for changes in their vision.
11. Extrapulmonary tuberculosis: TB disease where infection has spread outside the
lungs, this may include the pleural space, the central nervous system, the
genitourinary system, and the lymphatic system.
12. First-line TB drugs: the initial drugs used for treating TB disease. Include
isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), and either ethambutol
(EMB), or streptomycin (SM).
13. Foreign-born person: a person born outside the U.S. that currently resides in the
United States.
14. Foreign-born tuberculosis: tuberculosis infection that was likely acquired
outside the United States.
15. HIV seropositivity: testing positive for the presence of HIV antibodies in the
blood indicating infection with Human Immunodeficiency Virus.
16. Interferon-gamma release assay (IGRA): a type of blood test that measures a
person’s immune reactivity to M. tuberculosis by measuring release of IFN-γ. In
the US, QuantiFERON®-TB Gold, QuantiFERON®-TB Gold In-Tube, and TSPOT® TB are the currently available IGRAs brands.
17. Isolate: a sample from a specimen that was identified as a certain organism such
as M. tuberculosis complex.
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18. Isoniazid (INH): a drug that is used for treating LTBI and one of the drugs used
to treat TB disease; although relatively safe, it may cause hepatitis and other
severe adverse reaction in some patients.
19. Latent tuberculosis infection (LTBI): a state of persistent immune response to
stimulation by Mycobacterium tuberculosis antigens without evidence of
clinically manifested active TB. Persons with latent TB infection do not feel sick
and do not have any symptoms. They are infected with M. tuberculosis, but do
not have TB disease. The only sign of TB infection is a positive reaction to the
tuberculin skin test or TB blood test. Persons with latent TB infection are not
infectious and cannot spread TB infection to others.
20. Mantoux tuberculin skin test (TST): a method of testing for TB infection
sometimes referred to as a Purified Protein Delivery test (PPD), is where a
needle and syringe are used to inject 0.1 ml of 5 tuberculin units of liquid
tuberculin between the layers of the skin (intradermally), typically on the
forearm; the reaction to this test, a palpable swollen induration, is measured 48
to 72 hours after the injection and is interpreted as positive or negative
depending on the size of the reaction and the patient’s risk factors for TB.
21. Miliary TB: TB infection from a histological or radiologic finding, rather than a
site of disease. It appears on radiograph as many small, well-defined nodules
that resemble millet seeds scattered throughout the lungs, hence the name
“miliary.” Usually a very serious type of infection.
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22. Multidrug-resistant TB (MDR TB): TB organism that is resistant to at least the
drugs isoniazid and rifampin.
23. Mycobacterial interspersed repetitive units (MIRU): comprise short tandem
repeat structures found at multiple loci throughout the Mycobacterium tuberculosis
genome and are used for genotyping TB pathogens.
24. Mycobacterium tuberculosis complex (MTBC): a genetically related group of
Mycobacterium species that can cause tuberculosis in humans, the most
common of which is Mycobacterium tuberculosis.
25. Nucleic acid amplification (NAA): a laboratory technique that amplifies (copies)
DNA or RNA segments, to identify microorganisms in sputum specimens.
26. Pleural effusion: the abnormal accumulation of fluid in the space between the
lungs and chest wall.
27. Polymerase-chain reaction (PCR): a biochemical technology in molecular biology
used to amplify a single copy or a few copies of a piece of DNA across several
orders of magnitude, generating thousands to millions of copies of a particular DNA
sequence.
28. Polymorphism: a natural variation in a gene, DNA sequence, or chromosome
29. Pulmonary disease: TB disease that occurs in the lungs which accounts for most
(about 90%) active disease.
30. Purified protein delivery (PPD) test: a method of testing for TB infection. See
Mantoux TST above.
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31. Recurrence: a patient who has either a history of a (1) negative culture result
while receiving anti-TB therapy, but then at some point after therapy is
completed, either the culture result becomes positive for M. tuberculosis or the
patient has clinical or radiologic deterioration that is consistent with active TB
disease or (2) negative smear and culture result at diagnosis and while receiving
anti-TB therapy, but then at some point after therapy is completed, either the
patient has a culture result that is positive for M. tuberculosis or has clinical or
radiologic deterioration that is consistent with active TB disease.
32. Rifampin: a drug used to treat TB disease; also used for LTBI treatment.
Rifampin may have serious side effects such as hepatitis, turning body fluids
orange, and drug interactions.
33. Second-line TB drugs: drugs used to treat TB that is resistant to first-line drugs
such as capreomycin, kanamycin, ethionamide, cycloserine, ciprofloxacin, and
amikacin.
34. Singleton case: a TB case with an isolate that has a unique DNA fingerprint (i.e.
does not belong to a known genotype cluster).
35. Smear: a specimen that has been smeared upon a glass slide, stained, washed
with acid solution, and then placed under the microscope for examination. It is
used to detect acid-fast bacilli in a specimen.
36. Spoligotyping: spacer oligonucleotide typing, or spoligotyping, is a rapid,
polymerase chain reaction (PCR)-based method for genotyping strains of the
Mycobacterium tuberculosis complex (MTB).
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37. Sputum: phlegm from deep in the lungs, collected in a sterile container for
processing and examination.
38. Tuberculosis genotype cluster: two or more TB case-patients whose
Mycobacterium tuberculosis isolates have matching spoligotyping and 12-locus
mycobacterial interspersed repetitive unit–variable number tandem repeat
(MIRU-VNTR).
39. Tuberculosis genotyping: a laboratory-based genetic analysis of the bacteria that
cause TB disease and when combined with epidemiological data has sufficient
discriminatory power to determine TB cases likely to be in the same chain of
transmission or conclude that cases are not related.
40. Extreme-drug resistant TB (XDR TB): the occurrence of TB in persons whose
M. tuberculosis isolates are resistant to isoniazid and rifampin, plus resistant to
any fluoroquinolone and at least one of three injectable second-line drugs.
Assumptions
This study was based on three assumptions. First, most of the social (sometimes
referred to as “lifestyle”) characteristics on the RVCT were self-reported by the case.
The characteristics were assumed true for the purposes of this study. Some studies have
indicated that self-reported drug and alcohol use are generally underreported due to the
stigma associated with substance use disorders (Fendrich, 2004; Mensch, 1988;
Midanik, 1988; Romelsjo, 1995). However, no studies on the reliability and validity of
these specific questions from the RVCT have been conducted. But because TB health
department nurses visit their patients 2 to 3 times per week for as long as 9 months (in order to
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provide DOT), it cannot be ruled out that some of the lifestyle characteristics noted on the
RVCT were suspected/witnessed and then verified by the TB nurse. By this, I mean that a
patient may have denied drug abuse when questioned directly by the nurse, but over the course
of several visits, the nurse may have suspected this behavior and corrected the information in
the patient’s medical chart as well as the accompanying RVCT (which was part of the patient’s
medical chart). The extent to which “correction” of self-reported data was or was not a
systematic practice by TB nurses cannot be determined. Thus lifestyle factors, such as drug
abuse, were assumed to be a sensitive question of self-report. Another lifestyle factor that
would have been self-reported by the patient was alcohol abuse. However, the TB nurse would
have taken special care to verify the accuracy of this answer because alcohol consumption (and
especially abuse) is a contraindication to some TB treatment. Consequently, the accuracy of
the alcohol abuse question in this data set was expected to be high.
The second assumption was that the reliability and validity of the RVCT were
high; however, the literature review did not find any research that directly measured the
reliability or validity of the RVCT. This is discussed more in Chapter 3, Methodology.
Thirdly, that only active TB cases were counted in TB prevalence. People with
latent tuberculosis infection (LTBI) are not symptomatic, not contagious, and not
counted in TB disease prevalence rates. When they reactivate, they become active TB
cases and thus would be more likely to be detected by the South Carolina TB control
program, as they would manifest clinically diagnosable symptoms. Asymptomatic
contacts with positive skin tests that were treated to prevent progression to TB disease
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did not meet the CDC case definition for an incident or prevalent TB case. This was a
valid assumption and is true for most TB prevalence studies.
Limitations
This section will discuss the limitations of this study. The first limitation of this
study was that it is limited to those confirmed TB cases for which a valid TB genotype
could be obtained. There are two reasons a confirmed case may not have a valid TB
genotype. The first reason is when a TB case is confirmed without the benefit of a TB
positive culture (recall that a genotype cannot be performed without a TB cultured isolate
to perform it on). This is true for all cases that are exclusively extrapulmonary (TB cases
that have only extrapulmonary disease rather than both pulmonary and extrapulmonary
disease) because these cases are typically confirmed via some other testing methodology,
such as a PCR. This is true with the exception of extrapulmonary cases that are of the
pleural space of the lungs, which are usually confirmed, similar to pulmonary cases, using
sputum specimens. In fact, for all practical purposes are epidemiologically similar to
pulmonary TB. Thus, extrapulmonary cases of the pleural space were considered eligible
cases for genotype in the research sample as well as contagious cases that have contributed
to the chain of transmission in the community. Confirmed cases that may also not have a
TB culture are those pulmonary/pleural cases that are confirmed by some combination of
symptoms and testing other than a positive sputum culture. There are a few reasons why a
person with true TB pulmonary/pleural disease may not have had an M. tuberculosis
organism collected and/or isolated. These include, but are not limited to, (a) the patient
being lost to follow-up, thus no specimen was collected; (b) the patient received partial
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antibiotic treatment and thus had no viable organism in the specimen; (c) poor specimen
collection in that the specimen that is collected is not sputum from the lung but was
shallow esophageal mucous or saliva where little to no organism was present; and (d) poor
specimen shipping or transfer procedures resulting in viable organism expiring before it
could be cultured and identified; and (e) the patient being between the ages of 5 and 12
years when a sputum specimen is not only difficult to obtain but is also difficult to isolate,
thus alternative testing is often used to confirm these cases.
The second reason a confirmed case may not have a valid TB genotype was
because all TB isolates are not being genotyped. Ideally, all South Carolina TB diagnosing
laboratorians would send all their TB isolates to the National TB genotyping lab in
Michigan for genotyping. The goal for all states participating in the National CDC
Genotyping Surveillance program (of which South Carolina is one) in 2014 was 90%
participation and the goal for 2020 is 100% participation. However, South Carolina has
been falling well short of this goal. From 2005 to 2011, there were 1,346 confirmed cases
of TB in South Carolina. Of those, 1,080 were pulmonary/pleural only or both
pulmonary/pleural and extrapulmonary, thus 1,080 were eligible to be diagnosed by a
sputum culture. A valid genotype was available for only 685 (63%) of those cases.
In summary, the missing 37% of confirmed TB cases was a combination of four
possibilities: Either
A culture was not obtained (as mentioned above, this happened frequently in
children, and occasionally patients were lost to follow-up).
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M. tuberculosis was not isolated (again, this happens more frequently in
children and may happen if a patient has received partial antibiotic treatment).
The isolate was not sent for genotyping (the South Carolina lab did not follow
protocol).
or
The isolate was not able to be successfully genotyped.
Unfortunately, in my study sample I had no way of knowing what reason or
combination of reasons a confirmed TB case patient may not have had a successful isolate
and/or genotype. In the dataset I was provided by South Carolina DHEC, I had covariate
information for all the TB cases for which I also had a valid genotype. I had no way of
knowing in what ways those 420 (37%) incident TB cases without a valid genotype
differed from the 685 incident TB cases for which I did have a valid genotype. There was
no reason to believe these 685 cases were randomly selected for genotyping. This may
have introduced some bias into the estimate of recently acquired infection and in the
determination of risk factors for genotype clustering. To mitigate this limitation I used
publically available descriptive data on the TB incident case population of South Carolina
from 2005 to 2011 to compare with the fully genotyped sample on the covariates of
interest. These demographic variables were available through an intranet query site called
the CDC’s Online Tuberculosis Information System (OTIS) that provides data in 5-year
summary totals by state (CDC, 2016). The information from this site allowed me to
determine how alike or different my sample was from the entire sampling frame, and to
qualify my conclusions appropriately.
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In addition, this limitation also represented an opportunity. The opportunity to
emphasize the importance of comprehensive TB case genotyping, to characterize the
molecular epidemiology of TB in any jurisdiction or geography. This limitation and its
implications are further discussed in the recommendations section of Chapter 5.
A second limitation of this study was that any contribution that unconfirmed
symptomatic cases could play in the TB chain of transmission, and how this affected
my estimate of recent transmission, was unknown. Because some symptomatic
undiagnosed cases (those who never seek medical care and are under the health
department’s radar) will contribute to the chain of transmission, how these cases may or
may not differ with the study population regarding the independent variables of interest
cannot be explored. Therefore, any bias this introduced cannot be examined. However,
even the most robust TB control programs will miss cases. Again, how these cases
differ from the cases that are detected by public health surveillance systems are not
entirely clear. These cases may be more likely to be transient, underserved by the
healthcare community, possibly undocumented immigrants, or cases of subclinical
manifestation. This is a limitation for most TB genotyping prediction studies.
This third limitation of this study was that it was limited in place and time, in
that I was only able to examine genotypes of cases diagnosed within South Carolina
between 2005 and 2011. Cases diagnosed outside of this time period (either before or
after) within South Carolina; cases diagnosed within this time period but outside of
South Carolina; and cases diagnosed outside this time period (either before or after) and
outside of South Carolina, were not included in this study. Therefore, TB chains of
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transmission beyond the geographic and time boundaries set in this study were not
investigated. Certainly, this is a common limitation of all molecular epidemiological
studies, because researchers will always be limited by the data they collect or, as in the
case of this study, that which is secondarily available to them. However, because TB
transmission recognizes no time or state boundaries, this has implications for the
conclusions that may be drawn from this study’s findings. They are explored in Chapter
5, Conclusions, of this research.
The fourth limitation of this study was that while it was a population-based study,
it represented only individuals living in South Carolina. The fact that the study was
confined to South Carolina has implications for the generalizability of the study results.
While South Carolina has a growing urban population, a few modest-sized airports with
some international flights (such as to Canada and Mexico), and some public
transportation, it is somewhat behind many other states with regard to these factors,
especially those in the U.S. northeast. Thus, South Carolina may not be comparable to
U.S. urban northeast in terms of variety of TB, the presence of drug-resistance TB, and
conditions of urban overcrowding that may increase risk of transmission for TB. Using
public transportation and living among concentrated urban populations have been
shown to be risk factors for TB infection (Weis, 2002; Friske, 2011; Kirenga, 2015).
Further, South Carolina has few direct commercial flights from some of the highest TB
incidence regions, such as Africa and Indonesia. For these reasons, this study may not
be entirely comparable to U.S. states with (a) more concentrated urban populations, (b)
expansive, highly used public transportation systems, and (c) large international
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airports, because these three factors are likely to influence the amount and variation of
TB genotypes and clustering.
A fifth limitation of this study was that, for the purposes of answering Research
Question 1(b), what proportion of TB in South Carolina may be due to recent
transmission?, epidemiological information (dates of onset, diagnoses, etc.) was not be
reviewed. This determination was a simple mathematical calculation that provided a
reasonable indication of the proportion of South Carolina TB cases that could be due to
recent transmission. It was beyond the scope of this study to carry out an in-depth review
of source medical records to determine the true source for comparison to the
mathematically calculated determination. First, because the time it takes latent TB
infection (LTBI) to manifest as disease varies widely because it is often a result of both
known and unknown host factors. The dates of onset and diagnosis obtained may not be
helpful or reliable in determing source or index cases for clusters or outbreaks. Second,
most TB population-based molecular epidemiological studies do not use medial record
review to determine the proportion of recent transmission, but do it mathematically in just
the way I have outlined in Research Question 1(b). This was an acceptible limitation
because the methods used in this study were consistent with previous research and my
research is directly comparable to other studies of this nature.
Significance of the Study
One of five priority actions that the World Health Organization (WHO) has
outlined as necessary to accelerate progress towards the 2020 Global Tuberculosis targets
is to reach the missed cases. From a global perspective, about 3 million people who
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developed TB in 2012 were missed by national notification systems (WHO, 2013). As
part of the positive social change implications of this research, it is my hope that cases
that would have been missed when investigated with traditional contact investigation
alone will be discovered when employing targeted contact investigation informed by the
findings of this study. Genotyping may facilitate quicker confirmation of known contacts,
detection of unknown contacts, or revelation of transmission environments (Malakmadze,
2006, Yeo, 2006). If a jurisdiction participates in the U.S. national TB genotyping
program, consistently sends in all its confirmed case specimens for genotyping, and then
checks those results frequently, they may find linked cases that their standard contact
investigations did not reveal. In addition, TB contact tracers may confirm suspected
epidemiological links they were already investigating. This approach may help a
jurisdiction make decisions about how aggressive and widespread their contact
investigations should or should not be, where to focus limited resources, and whether
there are transmission environments that traditional contact investigations are missing.
This has been exemplified by clustering studies that have elucidated risk factors that
serve TB prevention efforts by informing TB control programs where to target limited
resources (Miller, 2002; Suffys, 1997).
Furthermore, this study has two long-term implications. First, these findings may
lead to better TB control efforts and thus interrupt the chain of transmission yield fewer
TB infections. This would bring the U.S. one-step closer to TB elimination. Second,
targeted contact-investigation informed by TB genotype results may yield an overall costsavings to the South Carolina TB Control Program and similar programs.
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Summary
TB is a current and immediate public health threat of worldwide importance. The
DTBE at the CDC has, as its long-term goal, the elimination of TB in the US. To this
end, my research examined factors that significantly contribute to being a part of an
identical TB genotype cluster in South Carolina between the years 2005 and 2011. As
part of the positive social change implications of this research it is my hope that cases
that would have been missed when investigated with traditional contact investigation
alone, will be discovered when employing targeted contact investigation informed by the
findings of this study. Furthermore, the long-term implications of this study may lead to
better TB control efforts with targeted contact investigation that results in an overall costsavings to the South Carolina TB Control Program and similar programs.
Chapter 2 will provide an in-depth discussion of the research on U.S. and
European populations with low incidence of TB that is similar to my study population.
Chapter 2 will also provide a framework for this research and describe the gap in the
literature that my research fills.
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Chapter 2: Literature Review
Introduction
This research examined (a) what proportion of South Carolina TB cases from
2005 to 2011 were due to recent transmission and (b) the risk factors among incident
cases that were significantly associated with being part of an identical TB genotype
cluster of two or more cases. The goal of providing additional clarity to South Carolina
TB transmission dynamics, and useful information to the South Carolina TB Control
Program. To frame this research and identify gaps in the literature, I reviewed applicable
studies on TB genotyping and the predictors for clustering in relevant populations. While
there have been population-based studies examining predictors for clustering in the U.S. and
other developed countries as well as the developing world, I found a paucity of studies in the
southeast U.S.. This reflected an important gap in the literature. The southeast U.S. remains
an area of high TB incidence, particularly among Black people. In the southern states,
TB is almost exclusively transmitted in relatively insular networks defined by race,
ethnicity, and SES (Moonan, 2012; Kempf, 2005). The reasons for this are not clear, but
in general, southern states provide less Medicaid funding per person; there is less funding
for infectious disease control and intervention; and there is less direct state funding to
public health departments (Salinsky, 2010; Reif, 2012; DHHS, 2013). Further, remnant
and non-traditional segregation may also play a role in this racial disparity for what is a
highly infectious disease transmitted person-to-person. These concerning questions
indicated a need for continued research. Certainly, the number of individuals suffering
from, or at risk of, TB in the developing world—as well in the crowded urban areas of the
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developed world of the US, Canada, and Europe—has prompted some important TB
genotyping studies in these geographic regions (Verner, 2004; Moonan, 2012; HernandezGarduno 2002; Kamper-Jørgensen, 2012,). However, this review was limited to those studies
that examined predictors for clustering in populations that were similar to my study
population, such as those in other industrialized countries that could be expected to have
similar TB incidence as the US.
The review begins with an overview of the search strategy. I then discuss the
history of tuberculosis. The first part of the review discusses the conceptual framework
behind tuberculosis genotyping. I then discuss the rationale for in the chosen statistical
analysis methods. Following that, I review the literature related to each of the covariates
I examined in my study. Finally, I discuss a review table of the various rates of
clustering and recent tuberculosis transmission observed in prior population-based
genotype clustering studies.
Literature Search Strategy
In this literature search, the following databases were used: CINAHL, Medline,
Health Sciences, ProQuest Health and Medical Complete, Ovid Nursing Journals, and
PubMed. I limited the searches to peer-reviewed journals published within the last 12
years. (Seminal research older than 12 years was also reviewed to provide historical
context.) In all searches, I used the following keywords or phrases: tuberculosis genotype
clusters, tuberculosis genotyping, tuberculosis clusters, molecular surveillance of
tuberculosis, molecular epidemiology of tuberculosis, and DNA fingerprinting of
tuberculosis.
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Tuberculosis Background
The causative agent of most human TB disease is an aerobic bacterium that was
discovered by Robert Koch in 1892, and later named Mycobacterium tuberculosis. The M.
tuberculosis complex (MTBC) includes four other TB-causing mycobacteria: M. bovis, M.
africanum, M. canetti, and M. microti. M. africanum is not widespread, but it is a
significant cause of tuberculosis in parts of Africa. M. bovis was once a common cause of
tuberculosis, but the introduction of pasteurized milk has largely eliminated this as a
public health problem in developed countries. M. canetti is rare and seems to be limited to
the Horn of Africa, although a few cases have been seen in African emigrants. M. microti
is also rare and is mostly seen in immunocompromised people (CDC, 2011). Historical
research indicates that by the time the causative agent was discovered every seventh
person in the world was likely already infected (Santic, 2013). The source of infection is
typically a person symptomatic with pulmonary, laryngeal or bronchial TB that then
transmits by infectious droplets to their close contacts. The most infectious person is
someone who in 1 milliliter (ml) of sputum will excrete around 10,000 TB germs, and this
sputum will be TB positive on microscopic tests. Because TB is acquired through airborne
transmission of droplet nuclei risk of infection has been shown to increase with nuclei
concentration in droplets and with time of exposure to these nuclei (Bass, 1990). Once an
individual has been infected, s/he remains infected for a long time, possibly progressing to
active disease, sometimes years after the initial infection. In healthy people, about 10% of
infected cases will progress to active disease. Conditions such as immunosuppression with
HIV, physical and emotional stress, and very young age all substantially increase risk for
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developing active disease after primary infection, the risk being highest among young
children. Development of TB disease may be due to reactivation of latent disease or to
reinfection. Effective treatment for TB was not developed until 1944 when streptomycin
was first used. This was later followed by isoniazid and rifamycin regimens, which
significantly increased the TB cure rate to as much as 95% (Suffys, 1997).
Most TB infection is concentrated in the lungs; however, extrapulmonary
tuberculosis is TB disease where infection has spread outside the lungs. This may include
the pleural space, the central nervous system, the genitourinary system, the lymphatic
system or the skeletal system. It may be more difficult to diagnose and treat. It is more
common in HIV-infected patients because it is related to the failure of the immune
response to contain M. tuberculosis, thereby enabling haematogenous dissemination and
subsequent involvement of single or multiple nonpulmonary sites (Lee, 2015). The
organism proliferates and disseminates throughout the body (“miliary” tuberculosis).
Cough may not be a typical symptom as the initial pulmonary infection may have passed
by this point. Symptoms of extrapulmonary TB are vague and include fever, weight loss,
night sweats, anorexia, and weakness. Extrapulmonary TB is much more common in the
developing world where no treatment, inadequate treatment, and treatment failure are
more common than in the U.S. (Lee, 2015).
Conceptual Framework
Because prompt identification of TB patients through symptom screening and
testing, along with evaluation of contacts, can be difficult in hard-to-reach populations,
thorough identification of TB contacts is more important than ever to achieving the
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national goal of TB elimination (Dade County Cluster, MMWR 2012). Genotyping may
facilitate quicker confirmation of known contacts, detection of unknown contacts, or
revelation of transmission environments (Malakmadze, 2006; Yeo, 2006). If a
jurisdiction participates in the U.S. national TB program, consistently sends all their
confirmed case specimens in for genotyping, and checks those results frequently they
may find linked cases their standard contact investigations did not reveal. In addition,
TB contact tracers may confirm suspected epidemiological links they were already
investigating. Importantly, this approach may help a jurisdiction make decisions about
how aggressive and widespread their contact investigations should or should not be,
where to focus limited resources, and if there are transmission environments their
traditional contact investigations are missing. This has been exemplified by clustering
studies that have elucidated risk factors, which serve TB prevention efforts by
informing TB control programs where to target limited resources (Miller, 2002; Suffys,
1997). Because the U.S. national TB genotype coverage (i.e. the proportion of
confirmed cases that are successfully genotyped) has increased from 51.2% in 2004 to
88.2% in 2010 (MMWR, 36, 2012), this has greatly expanded genotyping’s value in
characterizing populations at high risk for TB transmission and outbreaks.
The primary concept applied in this study is commonly referred to as
tuberculosis genotyping. Most simply defined, TB genotyping is the laboratory-based
genetic analysis of the bacteria that cause TB disease, and when combined with
epidemiological data has sufficient discriminatory power to help find TB cases likely to
be in the same chain of transmission, or determine that cases are not in the same chain
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of transmission. There are three primary methods for genotyping TB isolates: IS-6110based genotyping also known as restriction fragment length polymorphism (RFLP)
technique, MIRU-based genotyping, and spacer oligonucleotide typing also known as
spoligotyping-based genotyping. For this review, I will focus on MIRU-based
genotyping and Spoligotyping because those are the methods that were used in this
study. However, in this section, I will provide a brief discussion of RFLP technique as it
was used in some of the studies I will reference and it was a groundbreaking method for
genotyping.
One of the first methods for TB genotyping developed in the early 1990s was
RFLP technique, and it has been used extensively for TB genotyping and
epidemiological studies since that time. There is a substantial amount of research
indicating the accuracy of RFLP in determining TB genotype matches (Samper, 1998;
Barnes, 2003; Ellis, 2002; Love, 2008). It is the standard approach for the analysis of the
distribution of the insertion sequence IS6110 in different strains. Its basis is that isolates
from patients infected with epidemiologically unrelated strains of tuberculosis have
different RFLP patterns, or different distribution sequences of IS6110, whereas those
from patients with epidemiologically linked strains generally have identical RFLP
patterns. While it is a highly discriminatory method, it is also complex and time
consuming, as it requires sub-culturing isolates for several weeks to obtain sufficient
DNA for typing. Currently, large databases of IS6110-based genotypes are available for
TB control programs and researchers to review and use to compare strains. Because
strains with fewer than six IS6110 insertion sites have a limited degree of
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polymorphism, a supplementary method of genotyping may be required in this
circumstance, such as spoligotyping.
Spoligotyping was developed somewhat concurrently with RFLP and has been
used successfully in TB research for determining DNA patterns of M. tuberculosis
isolates (Barnes, 2003; Kempf, 2005). The direct-repeat locus in M. tuberculosis
contains 10 to 50 copies of a 36-bp direct repeat, which are separated from one another
by spacers that have different sequences. However, the spacer sequences between any
two specific direct repeats are conserved among strains. Because strains differ in terms
of the presence or absence of specific spacers, the pattern of spacers in a strain can be
used for genotyping. Spoligotyping has two advantages over RFLP. First, because only
small amounts of DNA are required, it can be performed on clinical samples or on
strains of M. tuberculosis shortly after their inoculation into liquid culture and thus it
has a faster turn-around time. Second, the results of spoligotyping are expressed as
positive or negative for each spacer thus they can be reported in a digital format (like
the results of MIRU analysis noted below) facilitating the creation of large web-based
databases. The primary limitation of spoligotyping is that it is less discriminatory than
either RFLP or MIRU. However, when used in conjunction with MIRU, as it was in my
study population, it has excellent matching power (Barnes, 2003).
A third method is MIRU-based genotyping. The genome of M. tuberculosis
contains many MIRUs, some having identical repeat units and others having repeats
that differ slightly in sequence and length. MIRU genotyping describes the number and
size of the repeats using a polymerase-chain-reaction (PCR) assay, followed by gel
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electrophoresis. The discriminatory power of MIRU genotyping is nearly as good as
that of RFLP but unlike RFLP, MIRU analysis can be automated and many strains
typed simultaneously, yielding results that can be digitally catalogued in a web-based
database. MIRU is technically simpler than RFLP and can be applied directly to M.
tuberculosis cultures without DNA purification first, thus resulting in a quicker turnaround. Because of the quicker turn-around of both the spoliogotyping and MIRU
methods, these are better for use in ongoing contact investigations than compared with
the RFLP method.
There is a substantial amount of research indicating the applicability of TB
genotyping in TB epidemiological investigations, especially in low to moderate incident
countries (Samper, 1998; Barnes, 2003; Ellis, 2002; Kempf, 2005,; Malakmadze, 2005;
Love, 2008). For example, in a U.S. study Malakmadze and co-investigators revealed
three clusters of 19 patients by matching patient isolates with all three methods: RFLP,
MIRU, and spoligotyping. Then researchers retrospectively performed medical record
reviews and patient interviews, which revealed that most of these clustered patients had
no obvious epidemiologic links, but the medical records did point to several previously
unrecognized locations of possible TB transmission. These unrecognized locations of
transmission were a single-room occupancy hotel, two homeless shelters, one bar, and
two crack houses. This study perfectly illustrates that transmission of TB among highrisk groups may go undetected for years when relying on patient recall alone. This is
because it is very difficult to obtain a complete contact list from persons with often
numerous and frequent transient living and socializing environments coupled with
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alcohol and drug abuse behaviors. In addition, this investigation particularly highlights
the value of using multiple methods for TB genotyping to confirm genotype matches,
and reveal previously unrecognized locations of transmission that may be targeted for
specific TB interventions (Malakmadze, 2005).
Statistical Analysis in the Literature
After a thorough review of population-based studies that have examined the
association of various risk factors for clustering, I found that most studies consistently
employ logistic regression to model this relationship. For the remainder of this chapter,
all correlational studies reviewed should be assumed to have used this technique unless
otherwise noted. Further, logistic regression was used as my primary data analysis
technique for Research Questions 2. Logistic regression was an appropriate choice
because it is a powerful and reliable statistical too and has been used for many decades in
health science research (Kleinbaum, 1988; Hosmer, 1989). The nature of these research
questions and the extensive use of logistic regression in the current literature to determine
the impact of independent variables have on the dependent variable indicate it was the
best option. Parsimonious model building via backward elimination of insignificant
covariates was applied when calculating adjusted odd ratios (aOR). Odds ratios >1.0 with an
associated p-value <0.05 were interpreted as a risk factor for clustering. Likewise odds ratios
<1.0 with an associated p-value <0.05 were interpreted as protective for clustering. Further
details regarding the statistical methodology used in my study are provided in Chapter 3.
Literature Review Related to Key Variables
Numerous studies have evaluated various demographic, social, and clinical
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factors on risk for clustering versus singleton, where singleton is defined as a TB case
that does not belong to a known genotype cluster (Love, 2009; Barnes, 1997; CachoCalvo, 2005; Cattamanche, 2006; Fok, 2008; Kempf, 2005; Chan-Yeung, 2006; Driver,
2006; Ellis, 2002). The body of literature that precedes my research used both first and
second-hand data collection from a variety of sources including, but not limited to: the
RVCT exclusively, the RVCT supplemented by retrospective medical record review,
first-hand comprehensive medical record review, first-person patient interviews and
medical record review, interviewer-administered questionnaires, or patient selfcompleted questionnaires. For this reason, the studies discussed in this literature review
represent a wide range of covariates that have been collected and examined in relation
to clustering. As with any research, my research was limited to evaluating only those
factors (i.e. covariates) for which my secondary data set contains complete and reliable
information. To those ends, the scope of this literature review and the list of covariates
below is limited to only those that examined in my research.
Two seminal studies worth highlighting are that of Fok’s 2008 meta-analysis on
36 population-based TB genotyping studies and Moonan’s 2012 US-wide
comprehensive genotyping and geospatial scanning estimate study. Both are referred to
multiple times in this chapter. Fok’s study is important because of its comprehensive
meta-analysis of prior research (Fok, 2008). Moonan’s study is important because it
examined all TB cases in the U.S. that had a genotyping result from 2005 to 2009, and
employed a geospatial scanning strategy to determine if matching genotype cases were
likely to be a result of recent transmission (Moonan, 2012.)
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Fok’s meta-analysis (which does not include any studies after 2007) found that
in countries with low TB incidence the characteristics of local birth, male sex, minority
race, substance abuse (alcohol abuse and injection drug use), and homelessness were
associated with TB clustering and recent TB transmission (a finding consistent with
other published studies). Similarly, in the US, Moonan found that the characteristics of
persons U.S. born, being male, members of a minority race or ethnic group, persons that
abuse substances and the homeless are at higher risk for TB clustering and recent
transmission, again a finding that is consistent with other U.S. studies.
Below, I have listed each covariate I examined in my study and a brief
description of what the body of literature has found in relation to clustering. Each
covariate is listed by the term I will use to refer to it for the remainder of this
dissertation. In parentheses beside the covariate is the category/alternative of that
covariate that previous research has usually observed (but not always) to be positively
predictive for clustering. Generally, studies have grouped covariates into the broad
categories of (1) demographic (2) social and (3) clinical. There may be some overlap
between categories, but I have taken care to group each of my covariates similarly.
Demographic

Country of Birth (Not Being Foreign-Born). For studies conducted in the U.S.,
U.S. natives are more likely to be part of genotype clusters than those of foreign birth.
This has also been observed in European studies, such that persons native to the country
of study origin are more likely to be part of a genotype cluster than those of foreign
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birth. For example, researchers conducting a study in the Netherlands found native-born
Danes at higher risk for clustering compared to those of foreign birth, and researchers
conducting a study in Italy find those native to Italy at higher risk for clustering than
immigrants (van Soolingen, 1999 & Moro, 2002, respectively).
A Massachusetts study by Miller and colleagues found an adjusted odds ratio
(aOR) of 2.29 (95% C.I. 1.69-3.12) for the association of clustering among U.S. born when
compared to foreign-born persons (2002). Additionally, Moonan’s a population-based study
(including all genotyped cases of TB reported to the U.S. National Tuberculosis
Surveillance System (NTSS) by the 50 states and the District of Columbia) observed an
aOR of 2.4 (99% C. I. 2.1-2.7) between clustering and U.S. birth (2012). In Denmark,
Kamper-Jorgensen and co-authors found that TB cases in large clusters (≥ 0) were 7.7 (3.6
-16.4) times more likely to be Danish born than non-clustered TB cases (2012).
Similarly, in a study from the Netherlands, van Soolingen and colleagues observed that not
being Dutch-born was protective for clustering in both Mediterranean and African-born
residents with aORs of 0.7 (95% C.I. 0.6-0.8) and 0.7 (0.6-0.9), respectively. They also
found that longer periods of residence in the Netherlands (> 2 years) was a risk factor for
clustering with an aOR of 1.4 (95% C.I. 1.1-1.8) (van Soolingan, 1999). In Italy (among
non-AIDS patients), the aOR was 1.44 (95% C.I. 1.08-1.92) for the association of nativeborn Italian nationality and clustering (Moro, 2002).
The reasons for this association are somewhat intuitive. First, persons born in
countries with high TB incidence are more likely to have acquired TB in their country of
origin prior to arriving to U.S. or Europe, as Western countries have comparatively low
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incidence. Thus, foreign-born persons may be more likely to have a singleton genotype if
their TB is diagnosed early after arrival. Second, native-born persons would likely have had
more time within their native country to have acquired and spread TB to their contacts, than
recently arrived immigrants. Essentially, foreign-born persons are more likely to have
acquired their TB natively within a genotype cluster in their country of origin and may or
may not propagate that cluster once they immigrate.
Age (younger). Most studies have found that younger age is a strong, independent
predictor of clustering. How age is categorized and the reference group varies by study, but
generally studies have observed that younger cases are more likely to be clustered while
older cases are less likely to be clustered (Kamper-Jorgensen, 2012; Zolnir-Dovc, 2003;
Barnes, 1997; Talarico, 2012; Moonan, 2012). In the Moonan population-based U.S.
study (that included all genotyped cases in the 50 states and DC from 2005-2009), when
investigators used 25-44 years as the reference age group they found that age 0-4 years
were positively associated with clustering (aOR = 3.1; 99% CI. 1.4-6.8) and >= 65
years was protective for clustering (aOR = 0.5; 99% C.I. 0.4-0.6) (Moonan, 2012).
Further, in an early study from central Los Angeles, Barnes and colleagues observed a
similar finding with an aOR of 4.1 (99% C.I. 1.1-15.1) associated with younger age
(1997). Another study from Arkansas found that among TB cases <65 years old 56.4 %
were clustered versus those >= 65 years old 43.6% non-clustered with p-value <0.0001
(Talarico, 2012). European studies have observed comparable results. In Slovenia,
investigators observed that clustering rate decreased as age increased from 46.4% (age
group under 35 years) to 19.5% (age group above 65 years) yielding an aOR of 0.42
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(95% C.I. 0.74-2.21) (Zolnir-Dovc, 2003). Maguire and colleagues observed a marked
dose response relationship with age and clustering in Londoners from 1995 to 1997.
When using 60 years of age and older as the reference group, authors observed those 019 years at the highest risk of clustering with an aOR of 2.65 (95% C.I. 1.59-4.44),
those 20 to 34 at the second highest risk with an aOR of 1.51 (95% C.I. 1.02-2.22) and
those 35-59 at the third highest risk with aOR 1.43 (95% C.I. 0.97-2.11).
The reason for the association of younger age and clustering may be that older cases
are more likely the result of reactivation of latent infection. In addition, it is important to
keep in mind that genotype studies must examine clustering over a limited period. Thus,
while older persons might be part of clusters, the ability of studies to detect clusters in
excess of their review period would be limited, and certainly, the use of the genotyping
in general to detect clusters originating 20 to 40 years ago would not be possible as the
technology did not exist. In summary, older people have had more cumulative time to
have been infected with TB and for this reason their disease is more likely to be the
result of reactivation than their younger counterparts; meaning the odds of infection
having been acquired before study initiation, outbreak detection, or cluster propagation
are greater in older persons than in that of younger persons.
Sex (male). For all studies where a sex association was observed, male sex was
independently associated with being part of a TB genotype cluster. While not all studies
have observed an association with sex and clustering (Franzetti, 2009; Driver, 2006;
Maguire, 2003; Cacho-Calvo, 2005). However, no studies (to date) have observed a
significant positive association between clustering and being female. The US-wide study
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by Moonan and colleagues (referred to earlier) found that men were 1.2 (95% C.I. 1.11.3) times more likely to be clustered than women. In an ethnically diverse region of
southern California, Rodwell and co-authors observed an aOR of 1.57 (95% C.I. 1.172.10) for men and clustering. Similarly, in Arkansas, Talarico and co-investigators
found that 48.2% of men were clustered versus only 28.0% of women with a p-value of
0.058 (2012). In Kamper-Jorgensen’s study from Denmark investigators observed that,
men were 2.5 times more likely to be clustered than women (2012). Results are similar in
direction and magnitude in the Ellis U.S. study of 7 sentinel surveillance sites, the
Driver study of New York City, and the van Soolingen study in the Netherlands (2002,
2006, and 1999, respectively).
The reasons males are at higher risk for clustering are not entirely understood
but probably work in concert with many of the same reasons men are at greater risk for
TB in general, including increased rate and effect of alcoholism, increased rate of
incarceration, more homelessness, more use of homeless shelters, greater delays in
seeking treatment, and possibly more social/congregate alcohol and drug abuse
behavior (Oeltmann, 2009).While most studies do control for some of these factors, no
one study or combination of studies could be expected to entirely control for these
complex social and clinical factors.
Race (Black). U.S. studies have consistently found that black race is a strong
independent predictor for being part of a TB genotype cluster. Most U.S. studies use nonHispanic white as a reference group when examining this association. In Moonan and coauthors’ study that included all genotyped cases in the U.S. from 2005 to 2009,
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investigators observed the following associations with clustering: an aOR of 2.4 (99%
C.I 2.2–2.7) for black, non-Hispanic; an aOR of 1.7 (99% CI 1.5–2.0) for
Hispanic/Latino; an aOR of 2.6 (99% C.I. 1.5–4.4) for native Hawaiian/Pacific Islander;
and an aOR of 1.5 (99% C.I. 1.3-1.8), when using non-Hispanic white as the reference
group. Talarico and co-authors observed similar results in an Arkansas cohort from 19962003 finding an aOR of 2.07 (95% C.I. 1.52-2.82) for non-Hispanic blacks and clustering
when compared to non-Hispanic whites (2011). Likewise results were similar in Texas
where Serpa observed TB cases clustered in 82% and 77% of blacks and whites, respectively
(p = 0.46) and additionally that cluster size was significantly larger in U.S. born blacks than
whites (p < 0.001) (2009).
Ethnicity (Hispanic/Latino). The association between being Hispanic/Latino and
clustering is not as clear as that of black race. A very early study from San Francisco found in
patients under 60 years of age being Hispanic to be a greater predictor (OR = 3.3, p-value =
0.02) for clustering than being black (OR = 2.3, p-value = 0.02) (Small, 1994). While one
important comprehensive U.S. study observed Hispanic/Latino a statistically significant
positive predictor for clustering, although less in magnitude than black race, that of Moonan
noted above. A few studies have suggested a protective relationship with being
Hispanic/Latino and clustering (Ellis, 2002; Weis, 2002).
Social
Homelessness (current, or within prior 12 months). Some studies have found that
being homeless in the year prior to TB diagnosis is a strong independent predictor for being
part of a TB genotype cluster (Moonan, 2012; Zolnir-Dovc, 2003; Ellis, 2002; Love 2009;
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Barnes, 1997; Driver, 2006; Rodwell, 2012). While not all studies that examined recent
homelessness as a potential predictor for clustering have observed a statistically significant
association (Moro, 2002; Diel, 2002), none have observed a protective association. In all
U.S. genotyped cases from 2005-2009, Moonan and co-authors observed that being
homeless within the last 12 months was significantly associated with clustering with an
aOR of 1.4 (99% C.I. 1.2-1.6) (2012). In an ethnically diverse region of southern
California, Rodwell and colleagues found an aOR of 3.44 (95% CI 1.65-7.18) for
homelessness (2012). In Slovenia, Zolnir-Dovc and colleagues also observed that a
history of homelessness was significantly associated with clustering with an aOR of
5.73 (95% C.I. 1.21-27.13) (2003). In England, Love and co-authors found an aOR of
5.5 (95% C.I. 1.2-24.1) for homelessness and clustering (2009).
The reasons postulated for homeless persons being at greater risk for clustering
vary but one reason may be that homeless people congregate in environments where TB
cases and outbreaks often occur such as homeless shelters or homeless ‘camps’
(McElroy, 2003; CDC, 2003; CDC, 2005). Additionally, this population may also have
delay in seeking medical care for diagnosis and treatment resulting in longer periods of
infectiousness and transmission (Tan de Bibiana, 2011; McAdam, 2009).
Homeless Shelter (current, or within prior 12 months). A few studies have
examined stay in a homeless shelter as a potential predictor, either as a subset of the
homelessness covariate or separate from homelessness. Similar to homelessness,
persons with a recent history of stay in a homeless shelter may be at higher risk for
clustering (Barnes, 1997; Malakmadze, 2005). In Los Angeles, Barnes and co-authors
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observed that compared with non-clustered patients, patients from clusters were
significantly more likely to have spent time at 3 shelters and other locations when at
least 1 patient in the cluster was contagious, and these locations were independent
predictors for clustering (1997). Barnes also noted that among non-homeless persons,
clustered patients were significantly more likely than non-clustered patients to have
used daytime services at any of three shelters (Barnes, 1997). Additionally, in a
Wisconsin study investigators observed that clustered cases were associated with
homelessness, residence in homeless shelters and single room occupancy hotels. This
apparent increased risk for clustering may actually be just better detection. Because
homeless shelters have been the site of several TB outbreaks in the U.S. (Barnes, 1997;
McElroy, 2003; CDC, 2003; CDC, 2005), many homeless shelters perform routine
PPD’s on residents. This intervention may result in better case finding, discovering
small clusters of two or three persons instead of the singleton cases that might have
been discovered outside the shelter environment where their genotype match (es) may
go undetected.
Incarceration (current, or within prior 12 months). A couple of studies have
found that being incarcerated in prison or jail is an independent predictor for clustering
(Moro, 2002, Kempf, 2005). Kempf and co-authors observed an aOR of 2.9 (95% C.I.1.36.6) (2005) for the association of clustering and residence in a correctional facility in the year
prior to diagnosis. In an Italian study Moro and co-authors observed that aOR of 2.03 (95%
C.I. 1.41-2.92) among non-AIDS patients, but did not observe a significant association
among AIDS patients (Moro, 2002). Importantly, Moonan’s U.S. wide population-based
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study (previously cited) did not observe an association with residence in a correctional
facility at the time of diagnosis (aOR 0.8; 99% C.I. 0.7-1.0) (2012). However, Moonan did
not examine incarceration within the year prior to diagnosis, only current incarceration.
The reasons for this observed association are several. Prisons and jails are locations
where TB outbreaks occur often, cases go unrecognized, and medical care is suboptimal.
TB transmission is facilitated by crowding, delay in diagnosis, treatment non-compliance,
improper isolation; healthy prisoners are mixed with unhealthy prisoners, and questionable
nutrition (Moro, 2002; Kempf, 2005). This population, especially in jails is transient. In
jails, PPDs are routinely placed on new inmates, but may never be read. Thus, cases may be
missed and later diagnosed on the outside.
Alcohol (current, or history of abuse.) Several studies have found that alcohol
abuse is one of the strongest risk factors for clustering. In Arkansas, rates of clustering
were 19.8% among those with a history of alcohol abuse versus 8.6% among those
without (p-value < 0.0001) (Talarico, 2011). Also, Ellis and Kempf observed similar
results among other U.S. populations (2002 & 2005, respectively). Moonan’s
comprehensive U.S.-wide study, noted earlier, also found a strong association between
clustering and being more likely to abuse substances with an aOR of 1.4 (99% C.I. 1.31.7), where substance abuse was any abuse of drugs or alcohol (2012). Non-U.S. studies
have observed similar results. In Londoners, Maguire and co-investigators found that
alcohol dependence was an independent risk factor for clustering with an aOR of 2.33
(99% C.I 1.46-3.72). In Slovenia, cases with a history of alcohol abuse were at a
significantly increased risk for clustering with an aOR of 1.88 (95% C.I. 1.10-3.23). In
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Germany, alcohol abuse was also strongly associated with clustering (aOR = 5.11, 95%
C.I. 2.77–9.43) (Diel, 2002). In Fok’s meta-analysis, alcohol abuse was strongly
associated with clustering in both low TB incidence populations with a pooled
unadjusted and adjusted OR of 2.2 (95% C. I. 1.6–2.9), and high TB incidence
populations with a pooled unadjusted and adjusted OR of 1.4 (95% C. 1.1–1.7) (2008).
Persons that abuse alcohol may be at greater risk for clustering for a number of
reasons. They may (1) congregate closely in social settings such as bars (2) have poor
recall of social contacts and events, thus are not able to provide a comprehensive
contact list to public health investigators, (2) have unknown, thus uncontrolled for comorbidities that increase their vulnerability for disease as well as decrease the time they
progress from infection to disease, (3) experience delays in diagnosis and treatment, or
(4) be more prone to treatment non-adherence due to the interaction of alcohol and
common TB drugs. These four issues may result in alcoholics becoming infectious
earlier and staying infectious longer more so than non-alcoholics, and then transmitting
to casual social contacts.
Illicit Drugs (current, or history of abuse). Some studies have found that
abusing illegal/illicit drugs is an independent predictor for clustering (Ellis, 2002;
Driver, 2006). In the Moonan study mentioned in the alcohol section above, where
investigators examined a composite variable that combined injection drug use, noninjection drug use and excessive alcohol abuse into one covariate called substance
abuse, they observed an aOR of 1.4 (99% C.I. 1.3-1.7) for all substance abuse and
clustering (2012). In an earlier study that used the same composite definition as the
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Moonan study and examined all U.S. TB patient genotyped isolates from 2004 to 2005,
investigators found that among U.S. born patients the odds of involvement in a countylevel genotype cluster were 2.3 (99% C.I. 2.0-2.7) for substance abuser versus a nonabuser. The odds of involvement in a county level cluster for foreign-born patient were
less, but still significant at 1.5 (99% C.I. 1.2-2.0) among those who reported substance
abuse (Oeltmann, 2009). Further, Oetlmann’s study observed that those who abuse
substances were more likely to have sputum smear positive disease and to experience
treatment failure (2009). The reasons postulated for this association are comparable to
those for the association of alcohol abuse and clustering. These may include poor
contact and social history recall, poor nutrition and other drug abuse related health
issues resulting in quicker progression from infection to disease, and delayed diagnosis.
Further, persons who abuse alcohol, crack cocaine, heroin, marijuana, and
methamphetamines have all been shown to experience significant weakening to one or
more important immunologic mechanisms (Gamble, 2006; Baldwin, 1997; Lysle, 2000;
Tashkin, 2002; Friedman, 2003; Mahajan, 2006).
In contrast with alcohol abuse, there is the additional issue. Drug addicts often
use secretly in covert locations, and may be unlikely to reveal these locations or druguse contacts to public health investigators due to the illegal nature of this habit.
Furthermore, often substance abuse occurs in enclosed spaces with intentionally limited
or poor ventilation and high volumes of human traffic likely increasing the odds of TB
transmission (Oeltmann, 2006; Oeltmann, 2009). Additionally it has been noted that

53
persons who abuse substances are less likely to seek treatment resulting in an extended
period of infectiousness and advanced disease at diagnosis (CDC, 2003).
Injection Drugs (subset of Illicit Drugs) (current, of history of abuse). Some
studies were able to stipulate this relationship by examining non-injection drug users
separately from injection drug users. The results of these studies varied. Kempf and coinvestigators found that clustered patients had a crude OR of 1.9 (95% CI, 1.1 to 3.3),
among non-injection drug users (2005) but no effect for clustering among infection drug
users. While Hernandez and co-authors observed that among patients 60 years and
younger that were injection drug users the aOR for clustering was 3.0 (95% C.I. 1.4 to
6.7) (2002). Fok’s meta-analysis found that injection drug was associated with
clustering in the 10 low incidence population-based studies they examined with a
pooled unadjusted and adjusted OR of 2.9 (95% C.I. 2.0–4.2) (2008). The reasons for
these inconsistent findings among studies are not entirely clear but may represent a
difference in the associated drug culture and the high-risk environments among the
study populations. For instance among European populations, ‘shooting galleries’ may
be common, where people might congregate and spread disease. On the other hand, this
may not be as prevalent in the U.S. where there might be less congregating among
injection drug users. While in the U.S. ‘crack houses’ are places where persons are
smoking drugs, congregating, and sharing TB germs which might be why Kempf’s U.S.
study observed an association among non-injection drug users only. Further, studies
have found that prolonged use of many inhaled or smoked drugs principally crack
cocaine, leads to increased coughing and other negative pulmonary effects (Leonhardt,
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1994) which may facilitate the spread of TB. It is worth nothing that to date, most
studies have not examined the drug abuse and clustering relationship to the granularity
of injection drug use versus non-injection drug use, but more research is needed.
Clinical
Human Immunodeficiency Virus (HIV) (seropositivity) (AIDS diagnosis). By
definition, confirmed TB cases that are HIV positive have AIDS because TB is one of
several conditions that coupled with HIV infection is an AIDS-defining condition.
Thus, HIV positive TB cases may or may not be aware of their HIV infection before
their TB diagnosis. However, once a patient tests positive for HIV concurrently with
their TB diagnosis they actually have three new diagnoses: HIV infection, ‘full-blown’
AIDS and TB disease. For this reason, all HIV positive persons in my study population
were considered AIDS patients and were analyzed as part of an HIV seropositivity
(inclusive of all HIV and AIDS cases) covariate analysis. Meaning, this analysis did not
attempt to distinguish those HIV positive persons that may or may not have been
diagnosed with AIDS prior to their TB diagnosis. Most other studies also assess HIV
seropositivity in this way and do not perform a subset analysis of AIDS cases or any
analysis by immune-competence among HIV infected persons.
A few U.S. studies have observed HIV seropositivity to be an independent
predictor for being part of a TB genotype cluster (Ellis, 1994; Talarico, 2011; Moonan,
2012) while others have found no relationship (Kempf, 2005; Rodwell, 2012). Ellis and coinvestigators observed a relative risk of 1.37 (95% C.I. 1.29% to 1.46%), p-value =
<0.001 for being HIV positive and clustering (2002). Small and colleagues found in

55
patients under 60 years of age an aOR of 1.8 (p-value = 0.04) for being HIV positive and
clustering (1994). Talarico and co-investigators in their Arkansas study observed that
HIV was significantly overrepresented in medium size TB clusters with 4.6% versus
4.0% (p-value < 0.0001) (2011). In Moonan’s U.S.-wide study investigators observed a
crude OR of 1.7 (99% C.I. 1.5–1.9) and aOR of 1.1 (99% C.I. 1.0–1.3) for being HIV
positive and TB clustering (2012).
Results of European studies have varied. Moro’s Italian study found that 60.2%
of AIDS cases were part of a TB cluster (p-value < 0.00001) (Moro, 2002). While
Franzetti’s study of immigrants residing in Italy found no relationship between HIV status
and clustering (2010). Also, Samper and colleagues in their Spanish study did not find a
relationship between HIV status and clustering (1993). Outside of the U.S. and Europe,
no significant relationship is noticeable between being HIV positive and TB clustering
particularly in areas with high TB incidence such as Uganda and South Africa (Asiimwe,
2009 & Verver, 2004, respectively). Some investigators hypothesize that this may be
because new TB cases in areas of high TB incidence are overwhelming attributed to
ongoing community transmission, where the general population is at such high risk for TB
regardless of their HIV status, thus HIV status as well as other clinical factors are less likely
to be observed to be associated with clustering.
The reasons why this association is inconsistent among studies are not entirely
clear. While HIV seropositivity does not necessarily increase the infectiousness of TB
cases, it does substantially increase the risk of progression from infection to disease and
this progression will happen much quicker than in immunocompetent persons.
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Immunocompetent individuals infected with M. tuberculosis have approximately a 10%
lifetime risk of developing TB (Hopewell, 2000) with half of the risk occurring in the
first 1-2 years after infection. However, HIV-infected individuals with latent TB are
about 20-30 times more likely to develop TB disease than those without HIV, or at a
rate of 8-10% per year (Daley, 1992). It has also been observed that in some outbreak
settings, 35-40% of HIV-infected patients exposed to TB in health care or residential
settings developed active TB disease within 60-100 days of exposure (DiPerri, 1989;
Daley, 1992). The speed and efficiency by which HIV infected persons develop active
disease may be the primary reason why they have been observed to be at higher risk for
clustering in some studies. Although why this positive association has been observed in
some U.S. studies (Ellis, 1994; Talarico, 2011; Moonan, 2012) and not others (Kempf,
2005; Rodwell, 2012) is unclear, but it may be related to the heterogeneity of the HIV
infected population under study. For instance, those immunocompetent HIV infected
persons (i.e. those people being effectively treated for their HIV and/or in early HIV
infection with high CD4 counts) probably do not experience quicker progression from
TB infection to disease while those who are immunocompromised do experience
quicker progression to TB disease.
Previous TB Diagnosis (yes). Very few studies on risk of TB clustering have
examined previous TB diagnosis as a risk factor. Most investigators choose to examine
previous TB treatment instead because previous TB treatment is associated with both
clustering and MDR-TB. Unfortunately, in my dataset I did not have complete and
verifiable information on previous TB treatment for many of my cases. Thus, this
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investigation examined previous TB diagnosis as a risk factor because it had the least
missing data. Previous TB diagnosis may be interpreted a few different ways. It could
mean (1) previously diagnosed untreated TB, (2) previously diagnosed treated TB, (3)
previously diagnosed TB occurring long enough in the past to be considered a separate
incidence or activation, and (4) or recent TB diagnosis outside the area of the current
public health system. However, according to the RVCT training manual a previous TB
diagnosis has a very specific case definition. A patient is considered to have had a
previous diagnosis of TB disease if TB disease was verified in the past or the patient
completed therapy for TB disease (even if the case-to-case interval is within 12
months); or the patient with TB disease was lost to supervision for more than 12 months
and now has verified TB disease again. The RVCT also notes that recurrent cases
within 12 months of completion of therapy should be considered previous diagnoses
regardless of whether the initial and the subsequent genotypes are the same or are
different (CDC, June 2009). The RVCT further emphasizes that written documentation
of the previous episode of TB disease is ideal. Nevertheless, states that if the TB disease
episode occurred years ago or in another location (e.g., other country); oral report of a
previous episode of TB disease is acceptable only when written documentation is not
available. Due to the strictness of the previous TB diagnosis case definition and
verification, I suspect this covariate to be of high validity in my sample.
In one recent study that examined previous TB, diagnosis the population was
Londoners. Hamblion and co-authors found previous TB diagnosis to be significantly
associated with clustering with an aOR of 2.1 (95% C. I. 1.5–3.0) (Hamblion, 2016). It
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is also worthwhile to discuss studies that have examined prior TB treatment as a risk
factor because prior TB treatment is also used to define prior TB diagnosis (on the
RVCT). A few studies have observed that having received previous TB treatment is a
risk factor for clustering. A South African study compared cases that were retreated for
TB after non-compliance from previous treatment compared to the reference group of a
newly treated cases and found an aOR of 2.36 (95% C.I. 1.08-5.13) for clustering
(Verver, 2004). In England, Love and co-authors observed an aOR of 3.7 (95% C.I. 2.26.5) for risk of clustering when comparing retreated cases versus new cases. Likewise,
Chan-Yeung and colleagues found an aOR 6.12 (95% C.I. 1.82-20.5) for clustering
when comparing retreated cases to new cases (Chan-Yeung, 2006). It is not entirely
clear why this may be occurring. Most U.S. studies have either not examined this
relationship or have not found an association. However, some studies have examined
previous TB diagnosis and found this to be a risk factor for clustering. Previous
treatment for TB may be an indicator of patient non-compliance for current treatment as
persons that have relapsing TB are likely to have this due to treatment failure or noncompliance. Treatment non-compliance and relapsing TB facilitate the spread even
among communities with comprehensive TB control programs.
Rates of Clustering and Recent Transmission
Because the literature suggests that in population-based studies TB isolates
sharing identical genotype profiles (also known as clustered isolates) are likely a result of
recently acquired infection (Driver, 2006; Ellis, 2002) many of these studies approximate
what proportion of TB in their population may be due to recent transmission from their
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cluster analysis. Because the proportion of recent TB transmission is a reflection of the
success of control measures, correctly accessing this is of public health importance.
Research Question 1(b) approximated recent transmission for my study population.
Studies have found varying rates of TB clustering and recent transmission among
different populations. Some clustering studies do not estimate the rate of recent
transmission from their clustering rates due to limitations of their study design. Table 1
summarizes these rates.
Table 1
Rates of Tuberculosis Clustering and Recent Transmission Observed in Previous PopulationBased Studies

Study (First Author, Publication Year,
Location)
Small (1994), San Francisco
Samper (1997), Zaragoza (Spain)
Barnes (1997), Central Los Angeles
van Soolingen (1999), The Netherlands
Verver (2001), South Africa
Moro (2002), Milan (Italy)
Kulaga (2002), Montreal
Diel (2002), Hamburg (Germany)
Ellis (2002), U.S. 7 Sentinel States
Hernandez-Garduno (2002),
Vancouver
Weis (2002), Tarrant County (Texas)
Maguire (2003), London
Pena (2003), Gran Canaria (Spain)

Time
Frame
199192
1993
199496
199397
199398
199597
199798
199799
199600
199600
199596
199597
1993-

Cases
(N)

Recent
Clustering Transmission
(%)
(%)

473
226

40.0
39.0

not estimated
not estimated

162

59.0

not estimated

4,266

46.2

not estimated

797

72.0

not estimated

581

41.1

28.1

243

7.0

4.0

423

33.9

20.6

10,752

48.0

not estimated

793

17.3

not estimated

159

48.0

36.0

2,042
145

22.7
72.3

14.4
58.5
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Zolnir-Dovc (2003), Slovenia
Cattamanchi (2005), San Francisco
Cacho-Calvo (2005), Madrid (Spain)
Kempf (2005), Alabama
Chan-Yeung (2006), Hong Kong
Driver (2006), New York City
Fok (2007), 17 countries-Meta
Analysis
Durmaz (2007), Malatya (Turkey)
Love (2008), England
Franzetti (2010), Italy
Talarico (2011), Arkansas
Kamper-Jorgensen (2012), Denmark
Rodwell (2012), Southern California
Moonan (2012), United States
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2001
199103
199298
199400
199900
200103
198802
200104
1998
199300
199603
199005
200508
200509

301

37.9

25.0

2,094

18.9

not estimated

448

50.7

not estimated

1,834

41.0

35.0

702

24.5

15.3

2,408
8810,752

36.2

27.4

7.0-72.3

not estimated

306
2,265

22.0
16.4

13.1
12.2

1,999

46.0

not estimated

993

39.5

not estimated

4,601

56.0

not estimated

832

58.0

45.0

36,860

23.1

23.1

Genotyping and Multidrug Resistant TB
One of the important uses of TB genotyping globally is to examine the strains
that are most frequently observed as multidrug resistant. The U.S. population has not
had extensive spread of multidrug resistant TB thus far. Most cases of MDR-TB in the
U.S. have been imported from countries where it is an increasing public health problem.
However, when isolated cases are detected in the U.S. it is important to determine the
source and the genotype of each case quickly so that local transmission can be ruled out.
This section of my literature review will discuss the importance of TB genotyping as a
tool to describe and combat MDR-TB.
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The European Concerted Action on New Generation Genetic Markers and
Techniques for the Epidemiology and Control of Tuberculosis conducted a metaanalysis to determine how widespread the Beijing/W genotype of M. tuberculosis was,
whether it was on the increase, and whether it had a tendency for drug resistance
(2006). Individual-level data on >29,000 patients from 49 studies in 35 countries were
combined to assess the Beijing genotype's prevalence worldwide and drug resistance.
The authors found four patterns for Beijing/W genotype TB, which they described as
follows:
1. endemic, not associated with drug resistance at high levels in most of East Asia,
lower levels in parts of the US;
2. epidemic, associated with drug resistance at a high levels in Cuba, the former
Soviet Union, Vietnam, and South Africa, lower levels in parts of Western
Europe;
3. epidemic but drug sensitive in Malawi and Argentina; and
4. very low levels or absent in parts of Europe and Africa.
This essential study established that Beijing/W genotype TB was an emerging in several
regions and a predominant endemic strain in others. It was also frequently associated
with drug resistance.
A study by Shubladze and colleagues from Georgia (in the former Soviet Union)
was conducted on 634 MDR-TB strains were examined for which an MDR phenotype
had been previously determined by the proportions method (2013). This study
investigated the frequency of major drug resistance mutations across rpoB, katG and

62
inhA loci of Georgian MDR-TB strains and explored differences between new and
previously treated patients. Rifampin resistance was seen in 92.9% of patients and INH
resistance was seen in 92.1% of patients; 67.2% and 84.3% of MDR strains harbored
respectively rpoB S531L and katG S315T mutations. The inhA C15T mutation was
detected in 22.6% of the strains, whereas rpoB H526D, rpoB H526Y, rpoB D516V and
inhA T8C were revealed at a markedly lower frequency (≤ 5.2%). The specific
mutations responsible for the rifampin resistance of 110 isolates (17.4%) could not be
detected as no corresponding mutant probe was indicated in the assay. All types of
predominant mutations were observed at higher levels in new cases. Authors concluded
that a large portion of Georgian MDR-TB strains have a strong preference for the drug
resistance mutations. Further, investigators surmised that MDR TB strains with these
mutations might continue to occur in Georgia even in the absence of antibiotic pressure.
A Mexican study by Macías and co-investigators whose goal was to determine
the frequency of drug resistance and the clonality of genotype patterns in M.
tuberculosis clinical isolates from pediatric patients (2011). Resistance to any anti-TB
drug was detected in 26.7% of the isolates; 23.3% and 11.1% were resistant to Isoniazid
and Rifampicin, respectively, and 11.1% strains were MDR-TB. Spoligotyping
produced 55 different patterns; 12/55 corresponded to clustered isolates (n = 47,
clustering rate of 52.2%), and 43/55 to unclustered isolates (19 patterns were designated
as orphan by the SITVIT2 database). Database comparison led to labeling of 36 shared
types (SITs); 32 SITs (n = 65 isolates) matched a previous shared type in SITVIT2,
whereas four SITs (n = six isolates) were newly created. Lineage classification based on
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principal genetic groups (PGG) showed that 10% of the strains belonged to Bovis and
Manu lineages. Among the Bovis and Manu group, the most predominant clade was the
Latin-American and Mediterranean (LAM) in 27.8% of isolates, followed by Haarlem
and T lineages. The number of single drug-resistant (DR) and MDR-TB isolates in this
study was consistent with prior studies in adult populations with risk factors.
Dhatwalia and colleagues conducted a study to determine the prevalence of
different genotypes and examine their association with drug resistance among clinical
isolates of M. tuberculosis from the northern region of India. Investigators analyzed 100
clinical isolates of M. tuberculosis using MIRU genotyping and TbD1 analysis. The
analysis showed that 34% of strains belonged to the Delhi/CAS lineage, 32% had
unknown patterns (27 TbD1-, 5 TbD1+), 18% were of Beijing genotype and 11% were
of EAI lineages. Twenty-one strains were MDR-TB, nine of which belonged to the
Delhi/CAS lineage, four were of Beijing lineage, six were of unknown pattern and one
was of EAI lineage. Their analysis showed the overall proportion of CAS lineage to be
42.96% (95%CI 33-52); the CAS lineage had no association with MDR-TB (OR 0.89,
95%CI 0.66-1.20). This study indicated that the distribution and identification of
different genotypes of M. tuberculosis could facilitate better understanding of the
dynamics that influence disease transmission and drug resistance.
In summary, TB genotyping has been used to successfully describe geographic
areas of high TB drug resistance and, in some cases predict continued spread of drugresistance. These studies underscore the need to continue to develop and expand
genotyping capabilities globally as MDR-TB and XDR-TB continue to emerge.
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Summary and Conclusions
This literature review provided background and evidence for my conceptual
framework, explained the rationale for my choice of statistical analysis, summarized
research on the risk factors for clustering, and reviewed clustering and recent
transmission rates observed in previous studies. Several population-based molecular
epidemiology studies have been conducted to estimate the extent of ongoing TB
transmission and to characterize recent transmission dynamics in different geographic
regions. Additionally, many of these studies have investigated risk factors for clustering by
comparing the characteristics of clustered and nonclustered cases. Some characteristics that
studies have consistently found to be associated with being part of a TB genotype cluster
were being native-born, being male, younger age, history of alcohol abuse, black race, and
history of homelessness. Some characteristics that studies have inconsistently found to be
associated with being part of a TB genotype cluster were being HIV positive, having
pulmonary disease, and illicit drug use. Better knowledge of transmission risk factors may
help to develop more effective prevention strategies to target high-risk populations. The bulk
of TB cases in developed countries with comparatively low TB incidence were once thought
to be due to the reactivation of infection acquired in the past. Since the advent of molecular
epidemiology, TB genotyping studies have strongly suggested that there is greater ongoing
transmission and development of active disease than previously appreciated. A better
understanding of the factors that influence TB transmission is therefore vital in the global
effort to control TB. The purpose of this research was to estimate the proportion of TB in
South Carolina that may be due to recent transmission, and determine the risk factors
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associated with the genotype clustering of identical M. tuberculosis isolates from TB
patients in South Carolina from 2005-2011. The social change implication of this study
was to further TB elimination by elucidating risk factors for ongoing transmission in
South Carolina, thereby informing the South Carolina TB Control Program and other
states’ control efforts. Chapter 3 will discuss the methodology of the study including the
population, sample size, data collection techniques, and data analysis procedures.
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Chapter 3: Methodology
In this chapter, I describe the research methodology used in this study, including
the rationale for the study design, the setting of the study, the study participants, the
instrumentation, the data collection, and the data analysis plan. I also discuss the
relevant ethical considerations. The goal of the study was to determine the risk factors
associated with genotype clustering of identical M. tuberculosis isolates, and to estimate
the proportion of South Carolina TB that could be due to recently acquired infection.
Study Design and Rationale
I used a cross-sectional approach to determine what risk factors among incident
cases of TB from 2005 to 2011 in South Carolina were significantly associated with
being a part of an identical TB genotype cluster of two or more cases. The risk factor
assessment for all confirmed cases of TB in South Carolina occurred at the time of TB
diagnosis (usually a few weeks prior to the determination of the case’s genotype).
Because risk factors were queried after TB disease had manifest, the RVCT assessment
was considered cross-sectional in nature. However, for the purposes of this study, as has
been the case in most studies of this kind, many of the risk factors I examined could be
assumed to have preceded TB diagnosis and in some circumstances, TB infection. The
risk factors analyzed as covariates were as follows: being U.S. born, being male, being
younger, being Black, being Hispanic, history of homelessness, history of incarceration,
history of alcohol abuse, history of illicit drug abuse, being HIV positive, and previous
TB treatment. Those risk factors for which it cannot be determined whether they
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preceded diagnosis are noted (as cross-sectional in nature) and interpreted accordingly in
Chapter 5.
Cross-sectional study designs have been used frequently to study risk factors for
TB genotype clustering (Oeltmann, 2008; Ricks, 2011; Moonan, 2012). A cross-sectional
study design has some advantages, for example, it is a low-cost design and the resulting
odds ratios are simple to calculate and easy to interpret (Creswell, 2009). However, crosssectional designs have limitations. The most important limitation is that they are unable
to determine whether the risk factor precedes the outcome of interest. This means that a
statistically significant association maybe illuminated between two factors but the
temporality of an exposure and outcome cannot be established in a cross-sectional study,
and thus causality cannot be established. However, in addition to the low cost and ease of
working with the resulting odds ratios, there are two other important points in defense of
the cross-sectional design. First, a general point: Even when temporality may be
established, such as with the longitudinal cohort design (for instance, one that results in a
strongly associated exposure and outcome); this, in and of itself, does not necessarily
establish causality. Temporality is but one of several criteria for causality. Bradford Hill’s
original nine criteria for causality are: (1) strength of association (2) temporality (3)
consistency (4) biological plausibility (5) coherence (6) specificity in the causes (7) dose
response relationship (8) experimental evidence and (9) analogy. All of these criteria are
rarely applied in modern epidemiology, and Rothman and Greenland have been critics of
them for reasons they explain in “Causation and Causal Inference in Epidemiology”
(Rothman & Greenland, 2005), most schools of Public Health still teach at least five of
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them. Those are (1) strength of association (2) temporality (3) consistency (4) biological
plausibility and (7) dose response relationship. Thus, even though a longitudinal design is
advantageous over a cross-sectional design in that temporality may be established, it may
not necessarily establish causality any more than a cross-sectional study. The second
point is that many of the risk factors examined in this study may be assumed to have
preceded TB diagnosis/disease. Thus, temporality was established due to the nature of the
risk factor. Table two lists each covariate examined, whether it could or could not
reasonably be assumed to have preceded TB diagnosis, and whether it could or could not
reasonably be assumed to have preceded TB disease/infection.
Table 2
Chronology of Potential Risk Factors for Tuberculosis Genotype Clustering

Risk factor
Age
Sex at Birth
Race
Ethnicity
Being U.S. Born
HIV Status
Homeless within the Past Year
Resident in a Correctional Facility
at the Time of Diagnosis
Alcohol Abuse
Drug Abuse
Injection Drug Use
Previous TB Diagnosis

Did this
proceed TB
diagnosis?
Yes
Yes
Yes
Yes
Yes
Unknown
Unknown

Did this
proceed TB
disease/
infection?
Yes
Yes
Yes
Yes
Yes
Unknown
Unknown

Yes
Yes
Yes
Yes
Yes

Unknown
Unknown
Unknown
Unknown
Yes
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Setting of the Study and Population
The setting of this study was the state of South Carolina from 2005 to 2011. The
population of South Carolina ranged from 4,012,012 in 2005 to 4,625,401 in 2010. The
incidence of TB in South Carolina ranged from 6.1 in 2005 to 3.0 per 100,000 population
in 2011 (1,346 TB confirmed cases in those 6 years. All South Carolina residents were
considered at risk for TB in the years preceding, during, and after this study. The
sampling frame for this study was confirmed cases of TB disease (n = 1,346) excluding
all exclusively extrapulmonary TB (n = 266) in South Carolina from 2005 to 2011, for a
total sampling frame of 1,080 pulmonary (including pleural) or both pulmonary
(including pleural) and extrapulmonary TB disease. This study did not use any sampling
procedures and all TB cases for which my dataset contained a valid genotype were
considered in the study analysis. The analysis dataset contained a valid genotype for 63%
of eligible cases in the sampling frame (n = 685) (see Table 3). This study did not use any
sampling procedures for two reasons. First, I wanted to use all genotype data available to
maximize statistical power. Second, as mentioned in Chapter 2 Limitations, I did not
have complete demographic, clinical, or social information on TB cases for which I did
not have a valid genotype. Thus, I did not have an entirely accurate way to verify the
randomness or accuracy of my sampling methodology. Table 3 displays South Carolina
TB statistics for 2005 through 2011, the associated sampling frame, and sample size per
year.
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Table 3
The Percentage of Confirmed Tuberculosis Cases in South Carolina with a Genotype
Determined, 2005-2011
Eligible
for
Genotypeb
214
178
175
146
138
121
108
1,080

Confirmed Case
Successfully Genotyping
Year Cases
Ratea
Genotyped
Ratec
2005 261
6.1
126
59%
2006 222
5.1
105
59%
2007 218
4.9
116
66%
2008 188
4.2
95
65%
2009 164
3.6
85
62%
2010 153
3.3
84
69%
2011 140
3.0
74
69%
3.0-6.1
685
63%
Total 1,346
a
Rate per 100,000 population.
b
Cases with pulmonary (including pleural) TB (may have both pulmonary and
extrapulmonary).
c
Rate calculated as cases genotyped per year/eligible for genotype.
Instrumentation
All information on covariates of interest for this study was obtained from the
RVCT. There is a copy of the RVCT displayed in Appendix A. The Centers for Disease
Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
prevention developed and owns all versions of this form. This form is provided to all
states for the purposes of collecting and reporting information to the CDC TB division on
all suspect and confirmed TB cases identified in the states. A training manual is provided
to state and local health departments on how to complete this form. All South Carolina
health department TB nurses are required to attend an in-person training on completing
this form. The CDC website states that the form may be used for relevant research
purposes, but should be properly bibliographed.
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Below, the specific questions on this form that were used for this study are listed
in the order in which they appear on the form.
1. Date of Birth (MM/DD/YYYY),
2. Sex at Birth (Male, Female),
3. Race (American Indian or Alaskan Native, Asian: Specify, Black or African
American, Native Hawaiian or Other Pacific Islander: Specify, White),
4. Ethnicity (Hispanic or Latino, Not Hispanic or Latino),
5. Country of Birth (U.S. born or born to a parent who is a U.S. citizen, Country of
Birth: Specify),
6. Month-Year arrived in the U.S. (MM/YYYY),
7. Site of TB Disease (Pulmonary, Pleural, Lymphatic: Cervical, Lymphatic:
Intrathoracic, Lymphatic: Axillary, Lymphatic: Other, Lymphatic: Unknown,
Laryngeal, Bone and/or joint, Genitourinary, Meningeal, Peritoneal, Other: Enter
Anatomic Code, Site not Stated),
8. HIV Status (Negative, Positive, Indeterminate, Refused, Not offered, Test Done,
Results unknown, Unknown),
9. Homeless within the Past Year (No, Yes, Unknown),
10. Resident in a Correctional Facility at the Time of Diagnosis (No, Yes, Unknown,
if Yes select one: Federal Prison, State Prison, Local Jail, Juvenile Correction
Facility, Other Correctional Facility, Unknown),
11. Alcohol abuse use in the Past Year (No, Yes, Unknown),
12. Injection Drug use in the Past Year (No, Yes, Unknown),
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13. Non-injection Drug use in the Past Year (No, Yes, Unknown), and
14. Prior TB disease diagnosis (No, Yes, Unknown).
The literature review found no reliability or validation studies for the RVCT
instrument used as part of the original data collection. However, in Table 4, I have listed
all the studies on risk factors of TB genotype clustering that have used all or part of the
RVCT as their primary data collection/abstraction source. All of these studies were
published in reputable peer-reviewed journals. The limitations of the RVCT form were
described Chapter 1: Introduction of Study—Limitations and are described further in
Chapter 5: Conclusions and Recommendations.

Table 4
Peer-Reviewed Studies Utilizing the Report of a Verified Case of Tuberculosis (RVCT)
First Author
(Publication Year)

Study Title

Publication

Driver (2006).

Molecular epidemiology of tuberculosis
after declining incidence, New York
City, 2001-2003.

Epidemiology &
Infection

Driver (2006).

Which patients’ factors predict the rate
of growth of Mycobacterium
tuberculosis cluster in an urban
community?

American J of Epi

Kempf (2005).

Long-term molecular strains in
Alabama, a state characterized by a
largely indigenous, low-risk population.

J of Clinical Micro.

Moonan (2012).

Using genotyping and geospatial
scanning to estimate recent
Mycobacterium tuberculosis
transmission, United States.

Emer Infectious Dis

Oeltmann (2009).

Tuberculosis and substance abuse in the
United States, persons acquired prior to
entering the U.S., 2005-2009.

Arch of Internal Med

(table continues)
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Ricks (2011).

Estimating the burden of tuberculosis
among foreign-born persons acquired
prior to entering the U.S., 2005-2009.

Public Library of Science

Rodwell (2012).

Factors associated with genotype
clustering of Mycobacterium
tuberculosis isolates in an ethnically
diverse region of southern California,
United States.

Infect. Genetic Evol

Talarico (2011).

Identification of factors for tuberculosis
transmission via an integrated
multidisciplinary approach

Tuberculosis

Data Collection
There were no recruitment procedures used in this study because the study is
based entirely on secondary data collected through normal TB case investigation and
confirmation procedures. The original data was collected as part of a South Carolina TB
case investigation. These investigations occurred for all suspected and confirmed cases of
TB in South Carolina, which is a requirement of all states receiving federal TB control
and prevention funding.
Data Analysis Plan
I constructed the methodology of my study to answer the following research
questions.
Research Question 1:
a) Using the mycobacterial interspersed repetitive unit (MIRU) genotyping
method, and spoligotyping, for cluster classification of tuberculosis cases in
South Carolina, I estimated the proportion of TB cases that were genotyped
clustered versus singleton?
b) Estimated the proportion of South Carolina TB cases that may be due to
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recently acquired infection the following logic was applied:
I.

For genotype clusters of only 2 cases: One case of the cluster was
assumed to be a souce case. One case of the cluster was assumed to be
the recently infected case.

II.

For genotype clusters of 2 or more cases: One case of the cluster was
assumed to be the source case. All other matches in the cluster were
assumed to be due to recent transmission.

Thus, C - 1, were counted as recently transmitted cases, where C was the
number of identical isolates in the cluster (based on the “n - 1 method” index
described previously).
Research Question 2: Determined the risk factors of genotype clustering among
incident South Carolina TB cases from 2005 to 2011 considering the following
hypotheses:
H0

There is no relationship between being foreign-born and being part of a
TB genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between being foreign-born and being part
of a TB genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between being foreign-born and being part
of a TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between age and being part of a TB genotype
cluster when controlling for other significant covariates.
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Ha1

There is a positive relationship between age and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between age and being part of a TB
genotype cluster when controlling for other significant covariates.

H0

There is no relationship between being male and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between being male and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between being male and being part of a
TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between black race and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between black race and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between black race and being part of a TB
genotype cluster when controlling for other significant covariates.

H0

There is no relationship between hispanic ethnicity and being part of a TB
genotype cluster when controlling for other significant covariates.
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Ha1

There is a positive relationship between hispanic ethnicity and being part
of a TB genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between hispanic ethnicity and being part
of a TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between residence in a correctional facility at the
time of diagnosis and being part of a TB genotype cluster when
controlling for other significant covariates.

Ha1

There is a positive relationship between residence in a correctional facility
at the time of diagnosis and being part of a TB genotype cluster when
controlling for other significant covariates.

Ha2

There is a negative relationship between residence in a correctional facility
at the time of diagnosis and being part of a TB genotype cluster when
controlling for other significant covariates.

H0

There is no relationship between homelessness within the past year and
being part of a TB genotype cluster when controlling for other significant
covariates.

Ha1

There is a positive relationship between homelessness within the past year
and being part of a TB genotype cluster when controlling for other
significant covariates.
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Ha2

There is a negative relationship between homelessness within the past year
and being part of a TB genotype cluster when controlling for other
significant covariates.

H0

There is no relationship between being HIV positive and being part of a
TB genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between being HIV positive and being part
of a TB genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between being HIV positive and being
part of a TB genotype cluster when controlling for other significant
covariates.

H0

There is no relationship between alcohol abuse and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between alcohol abuse and being part of a
TB genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between alcohol abuse and being part of a
TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between illicit drug use and being part of a TB
genotype cluster when controlling for other significant covariates.
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Ha1

There is a positive relationship between illicit drug use and being part of a
TB genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between illicit drug use and being part of a
TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between injection drug use and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between injection drug use and being part
of a TB genotype cluster when controlling for other significant covariates.

Ha2

There is a negative relationship between injection drug use and being part
of a TB genotype cluster when controlling for other significant covariates.

H0

There is no relationship between substance abuse and being part of a TB
genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between substance abuse and being part
of a TB genotype cluster when controlling for other significant
covariates.

Ha2

There is a negative relationship between substance abuse and being part
of a TB genotype cluster when controlling for other significant
covariates.
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H0

There is no relationship between having prior TB disease and being part of
a TB genotype cluster when controlling for other significant covariates.

Ha1

There is a positive relationship between having prior TB disease and being
part of a TB genotype cluster when controlling for other significant
covariates.

Ha2

There is a negative relationship between having prior TB disease and
being part of a TB genotype cluster when controlling for other significant
covariates.

My secondary dataset was provided in a Microsoft excel passphrase-encrypted
spreadsheet. For security reasons, the passphrase was provided verbally and was not
transcribed. For the analysis phase of this study, I imported the excel data into SAS 9.3.
SAS 9.3 was used to conduct all analysis. I cleaned the data as necessary by labeling,
formatting, and making sure all values were reasonable and valid. As mentioned in
Chapter 2, logistic regression is commonly used in cross-sectional studies to model the
relationship between a binary dependent variable and one or more explanatory or
independent variables (Hosmer & Lemeshow, 2000) and I used it to model my data. I
used SAS code to format the genotype variable, which was my dependent variable. I
examined how many different clusters were present in the data, the range of cluster size,
and what proportion of cases were clustered (had one or more matches) versus
singleton. I coded the dependent variable of interest called “clustered status” as a
character variable of “0” for singleton cases and “1”for clustered cases. The
independent variables were obtained from the questions on the RVCT.
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Independent variables. The rationale for inclusion of the covariates chosen was
that these factors have been found to be statistically significant risk factors of TB
genotype clustering in multiple previous studies (Love, 2009; Barnes, 1997; CachoCalvo, 2005; Cattamanche, 2006; Fok, 2008; Kempf, 2005; Chan-Yeung, 2006; Driver,
2006, Ellis, 2002). Categorical variables with two levels are coded as “1” for the level
that has been observed in the literature to be positively associated with being part of a
TB genotype cluster, and “0” for the other level. Country of birth was coded with “0”
assigned to foreign-born and “1” assigned to U.S. born. Date of birth was not provided
in the dataset, only age categories (so age was modeled as categorical variable rotating
both younger and older age groups as the risk factor see Chapter 5 Results for more
information). Sex was coded with “0” assigned to females and “1” assigned to males.
Race was a categorical variable divided as (1) White (2) Black (3) Hispanic, (4) Asian,
and (5) Other (the “Other” category was the collapsed category of American Indian or
Alaskan Native and Native Hawaiian or Other Pacific Islander). Homeless within the
past year was “0” as no and “1” as yes. Resident in a correctional facility at the time of
diagnosis was “0” for no and “1” for yes. HIV status was “0” for negative and “1” for
positive. Prior or current alcohol abuse was “0” for no and “1” for yes. Prior or current
drug abuse was “0” for no and “1” for yes. Prior TB diagnosis was coded as “0” for no
and “1” for yes.
By definition, confirmed TB cases that are HIV positive have AIDS because TB
is one of several conditions that coupled with HIV infection is an AIDS-defining
condition. Thus, TB cases may or may not be aware of their HIV infection before their
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TB diagnosis. However, once a patient tests positive for HIV concurrently with their TB
diagnosis they actually have three new diagnoses: HIV infection, ‘full-blown’ AIDS,
and TB disease. For this reason, all HIV positive people in my study population were
considered AIDS patients and analyzed as part of an HIV seropositivity, inclusive of all
HIV and AIDS cases, covariate analysis. This analysis did not attempt to distinguish
those HIV positive persons that may or may not have been diagnosed with AIDS prior
to their TB diagnosis. Most other studies also assess HIV seropositivity in this way and
do not perform a subset analysis of AIDS cases alone or any analysis by immunecompetence among HIV infected persons.
This study used a bivariate and multiple regression statistical analysis. This
approach made it possible both clarification of bivariate relationships, as well as a
determination of the degree of relationship between and among variables (Kleinbuam,
1988). A multiple logistic regression approach was appropriate for this study because it
allowed simultaneous consideration of multiple predictor variables for a binary outcome
variable, and subsequent stepwise model building (Hosmer, 1989). First, the bivariate
results of all risk factors were examined. Then multiple logistic regression analysis and
a stepwise modeling building process included variables with an alpha level of 0.10. For
a covariate to be included in the final model, it was statistically significant with a pvalue < 0.05. The odds ratio results from this analysis were examined and interpreted in
the context of the bivariate and multivariable analysis. Model fit statistics were
examined and interpreted. As is customary, odds ratios >1.0 with an associated p-value
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< 0.05 were interpreted as a risk factor for clustering. Likewise, odds ratios < 1.0 with
an associated p-value < 0.05 were interpreted as protective for clustering.
Ethical Considerations
For this study, I obtained Institutional Review Board (IRB) approval through
Walden University on March 17, 2017 (3-17-17-0080120). As a full-time employee of
the South Carolina DHEC Division of Infectious Disease Control, they provided me
patient-level identifiable data in the summer of 2012 by South Carolina DHEC. This data
was not available to the public. I was allowed to view this data as part of my job and it
was covered under the confidentiality agreement I had to sign and adhere to as an
employee. Since my departure from South Carolina DHEC, I have been covered under
the volunteer use agreement as a non-employee.
At the time of my employment, one identifiable passphrase-encrypted dataset was
kept on the South Carolina DHEC desktop computer for which I alone had passphraseprotected access. During the time of my employment, South Carolina DHEC procedures
for patient data protection were strictly followed including that identifiable data could
never be emailed, and it could only be shared with disease investigation staff who had
appropriate access rights. At the time just prior to my separation from South Carolina
DHEC, I de-identified all data that was to be used in this study. I de-identified the data
using the following procedures:
1. I created a randomly generated unique identifier for all subjects.
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2. I deleted all personal identifiable variables for each subject including first name,
last name, South Carolina TB case number, CDC TB case number, and patient
address including city, street, and zip.
3. I created an alias variable for HIV status. The term “HIV” or “AIDS” was not
included in any of the data I am using.
4. I deleted all variables except those pertinent to my analysis including any
variables or opened-ended comments that included the names of HIV related
medications.
The one original copy of the data I was provided was completely deleted and I
have had no access to identifiable data since my departure from South Carolina DHEC
in October of 2012. Per my volunteer data-use agreement (DUA) with South Carolina
DHEC, a copy of the de-identified data (described above) was placed on an encryptedpassword-protected jump drive. That data was then placed on my personal laptop in an
encrypted password protected file and the jump drive file was deleted. Entry to my
personal laptop was password protected and I was the only person that had access to
this data.
Informed consent was not obtained from any individual for this study for the
following reasons. (1) Inclusion of a subjects de-identified data did not pose any physical
or mental risk to the subjects. Any risks associated with primary data collection (such as
obtaining a TB specimen for diagnosis and genotyping, or TB treatment) would have
occurred as a part of the normal TB diagnosis and treatment procedures. The low to
moderate risks associated with TB diagnosis and treatment far outweigh the risks of
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having untreated and undiagnosed TB disease for the individual. Further, TB
investigation, diagnosis, treatment, and containment are required by South Carolina State
Law Title 44 – Health, Chapter 31 Tuberculosis, and Article 1. Any use of a patient’s
secondary data in no way contributed to those risks. (2) Data was provided to only myself
for the purposes of this study 2 to 8 years after it was originally collected, and all
identifiers were dropped from the data, thus subjects were not identifiable for which to
obtain informed consent. All descriptive data and results are displayed at an aggregate
summary level in this report and there was no risk of individual identification.
Summary
In this chapter, I discussed the rational for the study design, setting of the study,
study participants, instrumentation, data collection, data analysis plan, and any ethical
considerations. Cross-sectional study designs have been used in previous retrospective
population-based TB genotyping studies, and this was a reasonable and appropriate
approach for my study. Each research question was described. Bivariate and multiple
logistic regression analysis were used to calculate odds ratios for each covariate
examined in this study.
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Chapter 4: Data Analysis
The purpose of this research was to estimate the proportion of South Carolina
TB that may be due to recently acquired infection, and determine the risk factors
associated with the genetic clustering of identical M. tuberculosis isolates from TB
patients in South Carolina from 2005-2011 by using a multivariable logistic regression
technique to model risk factors for the binary outcome of being part of a TB genotype
cluster, yes or no. In this study, two research questions were tested by using appropriate
statistical methods. This chapter presents an overview of the results and findings of
these analyses.
Data Collection and Study Participants
I used a cross-sectional approach to determine the risk factors among incident
cases of TB from 2005 to 2011 in South Carolina that were significantly associated with
being a part of an identical TB genotype cluster of two or more cases. This study was
based entirely on secondary data collected through normal TB case investigation and
confirmation procedures. The incidence of TB in South Carolina ranged from 6.1 per
100,000 population in 2005 to 3.0 per 100,000 population in 2011, or 1,346 confirmed
TB cases over those 6 years. The sampling frame for this study was confirmed cases of
TB disease (n = 1,346), excluding all exclusively extrapulmonary TB (n = 266) in South
Carolina from 2005 to 2011, for a total sampling frame of 1,080 pulmonary (including
pleural) or both pulmonary (including pleural) and extrapulmonary TB disease. The
analysis dataset contained a valid genotype for 63% (685/1,080) of cases in the sampling
frame (see Table 3), or 50.9% (685/1,346) of all confirmed South Carolina TB cases from
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2005 to 2011. The study population was 685 confirmed cases of TB for which a valid
genotype was available. Table 5 displays South Carolina TB statistics from 2005 through
2011, including the associated sampling frame and sample size per year.1).
Table 5
The Percentage of Confirmed Tuberculosis Cases in South Carolina with a Genotype Determined, 20052011

Year
2005
2006
2007
2008
2009
2010
2011

Confirmed
Cases
261
222
218
188
164
153
140

Case Ratea
6.1
5.1
4.9
4.2
3.6
3.3
3.0

Eligible for
Genotypeb
214
178
175
146
138
121
108

Successfully
Genotyped
126
105
116
95
85
84
74

Genotyping
Ratec
59%
59%
66%
65%
62%
69%
69%

Total 1,346
3.0-6.1
1,080
685
63%
Rate per 100,000 population.
b
Cases with pulmonary (including pleural) TB (may have both pulmonary and extrapulmonary).
c
Rate calculated as cases genotyped per year/eligible for genotype.
a

In order reveal any bias that may have been introduced by not using a sampling
methodology, I compared the distribution of covariates in the cases that were genotyped
(the 685 cases of the study population) to all confirmed TB cases in South Carolina (the
1,346 confirmed TB cases) from 2005-2011. This was done to determine how closely the
genotyped sample resembled the entire case population. This is discussed in Results,
under Estimate of Recent Transmission.
Descriptive Statistics
Table 6 below describes the characteristics of the study population. Most cases in
the study sample were adults with 31% being between 25-44 years, 38% 45-64 years, and
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20% 65+ years old. Children under 15 years made up less than 1% of the sample. The
majority of the population was male at 67.6 %. Sixty-three percent of the sample was
Black, 16% White, 13% Hispanic, and 8% other races. Close to 80% of the cases were
US-born. Less than 9% were HIV positive. A little under 7% reported having been
homeless in the last year, and a little over 2% were incarcerated at the time of diagnosis.
Almost 29% of the study population were heavy drinkers, while over 15% reported illicit
drug use. Most of the drug users reported non-injection drug use, with only 1.3%
affirming injection drug use. Eleven percent of the sample were both alcohol and drug
abusers which is termed “substance abuse” for the purposes of this analysis. Lastly, for
96% of the study population this represented their first TB diagnosis, while 4% noted a
previous TB diagnosis.
Table 6
Summary of Descriptive Statistics for South Carolina Genotyped Tuberculosis Cases, 2005-2011

Variables
Age (Years)
00-04
05-14
15-24
25-44
45-64
65+
Age-Collapsed
Child (0 - 14 years)
Adult (15 - 64 years)
Elderly (65+)
Sex at Birth
Male
Female

Genotyped
Cases
(N=685)
N
%
3
1
75
215
259
132

0.44
0.15
10.95
31.39
37.81
19.27

4
549
132

0.58
80.15
19.27

463
222

67.59
32.41

(table continues)

88
Race/Ethnicity
Black
Hispanic/Latino
Asian American
White
Other (American Indian, Alaskan Native,
Native Hawaiian or other Pacific Islander)
Origin
US-born
Foreign-born
HIV Status
Negative
Positive
Unknown (Refused, Not offered, or
Missing)
Homelessness
Yes
No
Unknown
Correctional Institution
Yes
No
Alcohol
Yes
No
Unknown
Illicit Drug Use
Yes
No
Unknown
Non-Injection Drug Use
Yes
No
Unknown
Injection Drug Use
Yes
No
Unknown
Substance Abuse
Yes (yes to alcohol and drugs)
No (no to either alcohol, drugs, or both)
Unknown
Previous TB Diagnosis
Yes
No

432
88
50
109

63.07
12.85
7.3
15.91

6

0.87

545
140

79.56
20.44

571
60

83.36
8.76

54

7.88

45
638
2

6.57
93.14
0.029

15
670

2.19
97.81

195
485
5

28.47
70.08
0.73

104
574
7

15.18
83.8
1.02

103
575
7

15.04
83.94
1.02

9
669
7

1.31
97.66
1.02

79
601
5

11.5
87.7
0.73

29
656

4.23
95.8

(table continues)
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As shown in Table 7, the genotype lineages that occurred in South Carolina TB
patients between 2005 and 2011 were mostly EuroAmerican and East Asian with a few
IndoOceanic, East African Indian, Bovis type, and Africanum type. This study revealed a
modest diversity of circulating genotypes as would be expected in a low incidence region.
All of the genotypes are fairly common in the US.
Table 7
Distribution of Genotype Lineages among South Carolina Tuberculosis Cases, 2005-2011

Genotype Lineage
Africanum type
Bovis type
East African
Indian
East Asian
EuroAmerican
IndoOceanic
Unknown

Genotyped Cases
(N=685)
N
%
2
0.29
3
0.44
4
74
528
31
43

0.58
10.8
77.1
4.53
6.3

Results
Estimate of Recent Transmission
There were 1,346 confirmed cases of TB in South Carolina from 2005 to 2011. Of
those, a genotype was successfully obtained on 685. For this study, research question 1(a)
asked what proportion of TB cases in South Carolina are clustered versus singleton? Of
these 685 cases that were successfully genotyped, 419 were clustered, for a clustering
rate of 61.2% (419/685). Research question 1(b) asked what proportion of South
Carolina TB cases might be due to recently acquired infection? There were 76 different
clusters represented by the 419 clustered cases. Cluster size ranged from two2 to 39
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cases. As described in Chapter 3 Methodology, for genotype clusters of only two cases,
one case of the cluster was assumed a source case while one case of the cluster was
assumed the recently infected case. For genotype clusters of two or more cases, one case
of the cluster was assumed the source case and all other matches in the cluster were
assumed to be due to recent transmission. This method is often called the “n – 1 method”
and has been used in previous research to estimate recent transmission (Reza Allahyar
Torkaman, 2014; Ricks, 2009). This logic provided the calculation:
419 (clustered cases) – 76 (source cases) = 343 recently transmitted cases
This gives a recent transmission estimate of 343/685 or 50.1% for this study population.
Table 8 below displays the descriptive statistics of all TB cases compared to only
the genotyped cases. Chi-square analysis was performed to compare all South Carolina
TB from 2005 to 2011 to those cases that were selectively in 10 characteristics of interest.
For most characteristics, the genotyped cases were not significantly different from the
entire South Carolina case population. They were different in three characteristics: age,
non-injection drug use, and alcohol abuse. Meaning it appears from this analysis that
middle age and older cases were more likely to be selected for genotyping, abusers of
non-injections drugs were more likely to be selected for genotyping, and alcoholics were
more likely to be selected for genotyping. However, other than these three characteristics,
given that the study population was not randomly sampled (as discussed previously this
was a convenience sample that included all cases with a genotype for maximum
statistical power), this appears to be a reasonable representation of the South Carolina’s
TB case population from 2005 to 2011, with the exception of age. It is not surprising that
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our genotyped sample would not be representative in age. As we discussed previously
pediatric cases are not routinely genotyped because positive cultures on children are very
difficult to obtain. However, the reasonable similarity between our study sample and our
entire case population gives us better confidence that our estimate of recent transmission
of 50.1% is generalizable to 2005 to 2011 South Carolina TB cases. The limitations of
this estimate will be discussed more in the Limitations of the Study section below.
Table 8
Summary of Descriptive Statistics for all South Carolina Confirmed Tuberculosis Cases Compared to all
TB Genotyped Cases, 2005-2011

All Cases
(N=1,346)
Variables
Age
00-04
05-14
15-24
25-44
45-64
65+
Sex at Birth
Male
Female
Race/Ethnicity
Black
Hispanic/Latino
Asian American
White
Other (American
Indian, Alaskan Native,
Native Hawaiian or
other Pacific Islander)
Origin
US-born
Foreign-born
HIV Status
Negative

Genotyped
Cases
(N=685)

Pearson's R (pvalue) All Cases vs.
Genotyped Cases

N

%

N

%

69
33
137
385
453
269

5.13
2.45
10.20
28.60
33.70
20.00

3
1
75
215
259
132

0.44
0.15
10.95
31.39
37.81
19.27

863
483

64.10
35.90

463
222

67.59
32.41

799
196
104
230

59.36
14.56
7.73
17.09

432
88
50
109

63.07
12.85
7.3
15.91

17

1.26

6

0.87

0.999 (< 0.00001)

1,061
285

78.80
21.20

545
140

79.56
20.44

0.997 (0.003)

1,066

79.20

571

83.36

Clustered
Cases
(N=419)
N

%

0.985 (< 0.00001)

3
1
36
135
172
72

0.72
0.24
8.6
32.2
41.1
17.2

0.992 (0.018)

286
133

68.3
31.7

(table continues)

311
25
18
61

74.2
6
4.3
14.6

4

0.24

379
40

90.5
9.6

344

82.1
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Positive
Unknown (Refused,
Not offered, or
Missing)
Homelessness
Yes
No
Unknown
Correctional
Institution
Yes
No
Alcohol
Yes
No
Unknown
Illicit Drug Use
Yes
No
Unknown
Non-Injection
Drug Use
Yes
No
Unknown
Injection Drug
Use
Yes
No
Unknown
Previous TB Diagnosis
Yes
No

103

7.65

60

8.76

41

9.8

177

13.15

54

7.88

0.993 (< 0.00001)

34

8.1

69
1,275
25

5.04
93.13
1.83

45
638
2

6.57
93.14
0.029

0.997 (< 0.00001)

33
386
0

7.9
92.1
0

27
1,319

2.01
97.99

15
670

2.19
97.81

0.992 (0.008)

11
408

2.6
97.4

296
1,038
12

21.99
77.12
0.89

195
485
5

28.47
70.08
0.73

0.997 (< 0.00001)

140
275
4

33.4
65.6
0.95

172
1,160
14

12.80
86.20
1.04

104
574
7

15.18
83.8
1.02

0.997 (< 0.00001)

77
342
0

18.6
81.4
0

157
1,175
14

11.66
87.30
1.04

103
575
7

15.04
83.94
1.02

0.997 (< 0.00001)

77
337
5

18.4
80.4
1.2

15
1,317
14

1.11
97.85
1.04

9
669
7

1.31
97.66
1.02

0.997 (< 0.00001)

5
409
5

1.2
97.6
1.2

59
1,287

4.38
95.62

29
656

4.23
95.77

(table
23 continues)
5.5
0.997 (0.003)
0.995 (< 0.00001)

296

94.5

Characteristics of Clustered Cases
Table 9, below, displays the characteristics of non-clustered versus clustered
cases. For clustered cases, 68% were male, 74% were Black, and over 90% were USborn. Over 90% were over 25 years old. Just under 6% had a previous TB diagnosis.
Over 33% were alcohol abusers and about 18% were drug users. Less than 3% were
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incarcerated at the time of TB diagnosis. Less than 10% were recently homelessness, and
less than 10% were HIV positive. Based on the chi-square test results reported in Table 9
below, clustered cases were statistically more likely to be U.S. born, black, alcohol
abusers, abusers of non-injection drugs, and of older age.
Table 9
Characteristics of South Carolina TB Genotype Clustered and Non-Clustered Cases, 2005-2011
N=627, Clustered (n=382), Not Clustered
(n=245)
Variables
Age
Child (0 - 14
years) vs.
Elderly
Adult (15 - 64
years) vs.
Elderly
Old (2565+years) vs.
Young (0-24
years)
Sex at Birth
Male vs. Female
Race/Ethnicity
(White =
reference
group)
Black vs. White
Hispanic/Latino
vs. White
Other vs. White
Origin
US-born vs.
Foreign-born
HIV Status
Positive vs.
Negative
Homelessness
Yes vs. No
Correctional
Institution
Yes vs. No

Point
Estimate

95%
Wald C.I.

Wald Χ2

p-value

1.770

1.09-2.86

5.3454

0.0208

1.060

0.75-1.49

0.106

0.7447

(table continues)

2.060

1.29-3.28

51.58

<0.0001

0.329
0.550

0.18-0.61
0.28-1.09

18.67
2.41

<0.0001
0.121

5.570

3.66-8.47

64.47

<0.0001

1.390

0.78-2.50

1.2322

0.267

2.010

0.99-4.06

3.8052

0.0511

1.790

0.56-5.67

0.9666

0.3255
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Alcohol
Yes vs. No
Illicit Drug Use
Yes vs. No
Non-Injection
Drug Use
Yes vs. No
Injection Drug
Use
Yes vs. No
Substance
Abuse
Yes vs. No
Previous TB
Diagnosis
Yes vs. No

2.030

1.40-2.94

13.93

0.0002

2.060

1.28-3.32

8.7344

0.0031

2.150

1.32-3.50

9.5823

0.002

0.799

0.21-3.01

0.1101

0.74

2.260

1.30-3.93

8.26

0.004

2.320

0.92-5.83

3.192

0.074
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Bivariate Analysis
The second research question asks what are the risk factors for genotype
clustering among incident South Carolina TB cases from 2005 to 2011? This question
was first examined with a bivariate unadjusted analysis. As stated previously, the initial
sample size was 685 genotyped cases. For the purposes of all the logistic analyses, I
dropped cases for which I did not have complete information on all covariates. There
were 54 cases with unknown HIV status, 1 of which also had unknown drug and alcohol
history. There were 2 cases with unknown homeless status, 1 of which also had unknown
drug history and HIV status, and the other had unknown drug and alcohol history. When
substracting the cases dropped for unknown homeless history, HIV status, and alcohol
status there were 2 additional cases with unknown drug status. This resulted in 58 cases
with missing information that were dropped from our sample giving an analysis sample
of 627 cases for all logistic models; 382 clustered cases and 245 singleton cases. A
logistic analysis of the 58 cases dropped for missing data was performed to determine if
they were more or less likely to be clustered than the cases not dropped. The results of
this analysis are below in Table 10. No significant association between being dropped
and being clustered was observed. Thus, we can conclude there was no indication that
dropped cases were more or less likely to be clustered (or that clustered cases were more
or less likely to be dropped).
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Table 10
Dropped Data Analysis

Not Dropped
Dropped
Total
Dropped vs.
Not Dropped

Frequency
Percent
Frequency
Percent
Frequency

Not Clustered
245
35.8
21
3.1
266

Clustered
382
55.8
37
5.4
419

627
91.5
58
8.5
685

Percent

38.8

61.2

100

Point
Estimate

95% Wald C.I.

Wald Χ2

p-value

1.130

0.65-2.0

0.184

0.668

As noted earlier, the age variable was only available in the data as a categorical
variable (I was not provided date of births in my dataset). Its original categories (as used
by the RVCT) were 0-4, 5-14, 15-24, 25-44, 45-64, and 65+ years. When the crude model
of age (in these original categories) and clustering was examined, no associations were
observed. I decided to collapse the two youngest age groups into 0-15 years as “child”
because there were so few children in the sample. This was used as the reference group.
The 3 middle age groups were collapsed into 24-64 years and called “adult”, and 65+
years was called “elderly”. With these new classifications, there was still no association
noted for clustering for either child versus elderly or adult versus elderly. Recall from
Chapter 2 Literature Review, there was a lot of variation with regard to classification of
age groups in prior studies, as well as variation in what ages were found to be at risk for
clustering. Additionally, because my sample had very few children (n = 4) it seemed
prudent to further collapse these categories to see if any association could be detected with
larger groups of wider age ranges. Thus, I further collapsed my age categories and tested
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the bivariate association between risk of clustering and age where “young” was the
reference group (0-44 years) and old was the risk group (45-65+ years). Table 7 below
shows that this association was statistically significant with an unadjusted OR of 1.77
(95% C.I. 1.09-2.86) or people over 44 years old were about 1.8 times more likely to be
part of a TB genotype cluster than people 44 and younger.
The next crude model examined was sex and TB clustering. Although much of the
literature indicates men may be at higher risk for clustering, no association was observed
in my population between male sex and risk of clustering, or female sex and risk of
clustering. Further, neither of these were significantly protective for clustering.
The next demographic variable examined was the bridged race/ethnicity variable.
Although the RVCT does actually inquire about both race and ethnicity as two separate
questions, the dataset I was provided only contained this information as a bridged variable
(Meaning the data did not allow me to discern non-Hispanic White or Black persons or
Hispanic White or Black persons. The only categories available to me were Black,
Hispanic, Other, and White). When this variable was examined using White as the
reference group (as is done most often in the literature), people of Black race were
observed to be at higher risk for clustering with a crude OR of 2.06 (95% C.I. 1.29-3.28).
Interestingly, Hispanics when compared to Whites displayed a statistically significant
protective effect for clustering, with a crude OR of 0.33 (95% C.I. 0.18-0.61). Based on
the finding that Blacks and Whites were at significantly higher risk for clustering when
compared to Hispanics, I became suspicious there may be an interaction occurring
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between origin (US-born versus Foreign-born) and race in this population. I explored this
possibility in the multivariable stage of this analysis discussed in the next section.
The next potential predictor variable that was examined was origin classified as
US-born versus Foreign-born. In the crude analysis, being US-born was highly predictive
of genotype clustering. Specifically, U.S. born TB cases had over 5.5 times the odds of
being part of a genotype cluster than did Foreign-born cases in the unadjusted analysis
(OR = 5.57, 95% C. I. 3.66-8.57). In fact, in the unadjusted analysis US-birth was the
greatest risk factor for clustering.
Next I examined the crude model of HIV status and clustering. Despite what
previous U.S. studies have observed, the bivariate analysis did not show being HIV
positive as a risk factor for clustering in this study population. Further, for the crude model
of living in a correctional facility at the time of diagnosis and clustering, again despite the
positive association some previous studies have observed, no association was observed in
my study population. However, being homeless or having been homeless in the year prior
to diagnosis was significant enough (at an alpha of 0.10) to be included in the multivariate
stage of the analysis with a crude OR = 2.01, 95% C.I. 0.99-4.06. Additionally, alcohol
abuse in the year prior to diagnosis was significantly associated with clustering with a
crude OR of 2.03 (95% C.I. 1.40-2.94). In addition, drug abuse was significantly
associated with clustering with a crude OR of 2.06 (95% 1.28-3.32). When drug abuse
was divided into injection drug-users and non-injection drug users, the association
remained significant only among non-injections drug users, and in fact, it slightly
increased. I found there was a lot overlap between drug and alcohol users so I decided to
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combine this into a single covariate called “substance abuse” as has been done in other
U.S. studies (Moonan, 2012). Substance abuse (alcohol and drug abusers inclusive)
became an even more significant predictor in the unadjusted model with an OR of 2.26
(95% C.I. 1.30-3.93) than either alcohol or drug, abuse was alone. Lastly, having had a
prior diagnosis of TB was significant enough to be included in the multivariate stage of
the modeling with a crude OR of 2.32 (p-value = 0.074). All bivariate results are
summarized in Table 11.
Table 11
Bivariate Analysis of the Association between Tuberculosis Genotype Clustering and Covariates of Interest
N = 627, Clustered (n = 382), Not Clustered (n =
245)
Variables
Age
Child (0 - 14
years) vs.
Elderly
Adult (15 - 64
years) vs.
Elderly
Old (2565+years) vs.
Young (0-24
years)
Sex at Birth
Male vs.
Female
Race/Ethnicity
(White =
reference
group)
Black vs. White
Hispanic/Latino
vs. White
Other vs. White
Origin
US-born vs.
Foreign-born

Point
Estimate

95%
Wald C.I.

Wald Χ2

p-value

1.770

1.09-2.86

5.3454

0.0208

1.060

0.75-1.49

0.106

0.7447

2.060

1.29-3.28

51.58

<0.0001

0.329
0.550

0.18-0.61
0.28-1.09

18.67
2.41

<0.0001
0.121

(table continues)
5.570

3.66-8.47

64.47

<0.0001
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HIV Status
Positive vs.
Negative
1.390 0.78-2.50
1.2322
0.267
Homelessness
Yes vs. No
2.010 0.99-4.06
3.8052
0.0511
Correctional
Institution
Yes vs. No
1.790 0.56-5.67
0.9666
0.3255
Alcohol
Yes vs. No
2.030 1.40-2.94
13.93
0.0002
Illicit Drug
Use
Yes vs. No
2.060 1.28-3.32
8.7344
0.0031
Non-Injection
Drug Use
Yes vs. No
2.150 1.32-3.50
9.5823
0.002
Injection Drug
Use
Yes vs. No
0.799 0.21-3.01
0.1101
0.74
Substance
Abuse
Yes vs. No
2.260 1.30-3.93
8.26
0.004
Previous TB
Diagnosis
Yes vs. No
2.320 0.92-5.83
3.192
0.074
Statistically significant at alpha <0.05 bivariate association.
Significant at alpha <0.10, variable examined in the multivariable model.

Multivariable Analysis
Additionally, the second research question asks what are the risk factors of
genotype clustering among incident South Carolina TB cases from 2005 to 2011, when
controlling for significant covariates? To answer this question a stepwise multivariable
analysis was performed. The stepwise multiple logistic regression model included all
covariates that were significant in the bivariate modeling with an alpha of <0.10. These
were origin, race, age, substance abuse, homelessness, and previous TB diagnosis. HIV
status, correctional institution, and sex were not included in this stepwise analysis
because they were not significant in the bivariate analysis. The results of the stepwise
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multivariable analysis are shown in Tables 12 and 13 below (the full stepwise selection
process is shown in Appendix B, Table B1).
Table 12
Odds ratios from the Best-Fit Logistic Regression Analyses of Tuberculosis Genotype Clustering and
Associated Risk Factors
N=627, Clustered (n=382), Not Clustered (n=245)

a

Main Effect

Odds Ratio Estimates
(95% C.I.)a

Origin, US-Born vs.
Foreign-Born

5.67 (2.12% to 15.14%)

Wald Χ2

Wald p-value

11.998

0.0285

Race, Black vs. White
1.96 (1.26% to 3.14%)
9.060
0.0005
Wald 95% confidence intervals given in parentheses. Only significant predictors are listed.

Table 13
Model Fit Statistics from the Best-Fit Logistic Regression Analyses of Tuberculosis
Testing Global Null Hypothesis: BETA=0
Test
Chi-Square DF
Pr > ChiSq
Likelihood Ratio
71.574
1
<.0001
Score
72.485
1
<.0001
Wald
64.465
1
<.0001
Model Convergence Status: Convergence criterion (GCONV=1E-8) satisfied.

In the multivariable analysis, the only factors that remained significantly
predictive for genotype clustering were being U.S. born, and being of Black race.
Specifically, people US-born were over 5.5 times more likely to be part of a genotype
cluster than those of foreign birth. People of Black race were almost 2 times more likely
to be part of a genotype cluster compared to people of White race. As shown in Table 12,
this final model was a good fit for genotype clustering with a large and significant
Likelihood Ratio and Wald Score.
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As part of the multivariable stage of the analysis, interaction terms were also
tested. The interaction terms were tested in separate versions of the multivariable model
where some insignificant covariates were added in order to assess the possibility of
interaction. The most common method of incorporating an interaction term in a
multivariable model is to create a product term. I did this by creating a variable whose
value is the product of two independent variables (i.e., the 2 variables for which I was
assessing a possible interaction multiplied by each other). Because a product term
describes the relationship between two risk factors and an outcome, it can only be
interpreted as an interaction if the two risk factors are in the model. Interaction terms
were chosen because both of the covariates were significant in the crude model, and/or
previous research has observed effect modification. The interaction terms that were
tested were (1) origin and race, (2) origin and previous TB disease, (3) origin and
substance abuse, (4) origin and HIV status, (5) previous TB disease and race, (6)
substance abuse and race, and (7) HIV status and race. None of these interaction terms
was significant in an adjusted model, and they were not included in the final model.
Please see Table 11 above for the final model. For reference, Appendix B Table B2
shows the tested models including interaction terms.
Summary
This was a non-experimental, cross-sectional population-based molecular
epidemiological study of TB in South Carolina from 2005 to 2011. The purpose of the
study was to estimate the rate of recent TB transmission and investigate the relationship
between TB genotype clustering and potential risk factors. The data was analyzed using
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the “n - 1 method” of calculating recent TB transmission and multiple logistic regression
to examine risk factors for clustering. The results indicated that about 50% of TB in
South Carolina might be due to recent transmission. Additionally, the study revealed U.S.
birth and Black race were independently and significantly associated with being part of a
TB genotype cluster of two or more cases. In Chapter 5, I will further discuss the results
of the research questions including interpretations, limitations of the study, implications
for social change, and recommendations for future research.
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Chapter 5: Conclusions and Recommendations
The purpose of this research was to estimate the proportion of South Carolina TB
that may be due to recently acquired infection, and to determine the risk factors
associated with the genetic clustering of identical M. tuberculosis isolates. In doing so,
my objective was to provide suggestions to the South Carolina TB control program
informed by the molecular epidemiology of TB in the state, as well as to articulate
recommendations for future research. This was a non-experimental, cross-sectional,
population-based molecular epidemiological study of TB in South Carolina from 2005 to
2011. The study population included 685 genotyped TB cases. I answered RQ1 using the
“n - 1 method” for TB recent transmission estimation, and RQ2 using multiple logistic
regression analysis to examine the association between TB clustering and predictors. The
study results strongly suggested that about 50% of TB in South Carolina has been
recently transmitted. Further, the analysis revealed several associations. The results of the
bivariate analysis indicated a positive relationship between being U.S. born and genotype
clustering, being Black and genotype clustering, older age and genotype clustering, being an
alcoholic and genotype clustering, being a drug abuser and genotype clustering, and being both
an alcohol and drug abuser and genotype clustering. The bivariate analysis also indicated that
being Hispanic was protective for genotype clustering. In the multivariable analysis, the only
factors that remained significantly predictive for genotype clustering were being U.S. born and
being Black. In the next section, I interpret these findings.
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Interpretation of Findings
Before discussing the research questions individually, I will discuss the results of
the descriptive statistics performed. The study population (685 genotyped cases) and the
entire state case population (1,346) were very similar with regard to the covariates of
interest (see Table 8). Both were mostly adults, and the majority were men. Black was the
most prevalent race, followed by White, and then by Hispanic and other. For both
populations, close to 80% of the cases were born in the U.S. Both populations contained less
than 9% HIV positive, less than 7% homeless, and less than 3% were incarcerated at the
time of TB diagnosis. About 30% of South Carolina TB cases included in the study reported
alcohol abuse, compared to about 20% for all TB cases from 2005-2011. The rates of drug
abuse, particularly injection drug abuse, were low among both populations. For over 95% of
TB cases in South Carolina this was their first TB diagnosis and this was also true for the
genotyped cases (i.e., the study population). Chi-square analysis indicated that the study
population was a reasonable representation of the entire case population of the state
with the exceptions of that genotyped cases were older, more often alcoholic, and more
often drug abusers (see Table 8). Particularly, children were underrepresented in the
study sample (X2 = 46.4, p-value < 0.0001).
South Carolina’s estimated rate of recent transmission of about 50% is in
keeping with previous studies in the southeast U.S., if somewhat higher. Kempf’s 2005
Alabama study observed a recent transmission rate of 35% (Kempf, 2005). Talarico’s
2011 Arkansas study did not estimate recent transmission but observed a high clustering
rate of about 39% (Talarico, 2011). While Weis’s 2002 Tarrant County, Texas, study
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estimated a rather high recent transmission rate of about 36%, and Moonan’s US-wide
study estimated a recent transmission rate of about 23% (Weis, 2002, Moonan, 2012).
In comparison with these previous findings, this study’s estimate of recent transmission
is higher. The estimate of recent transmission of 50% is outside the range of previous
studies for low incidence countries with the highest estimate noted from a Southern
California study of 45% (Rodwell, 2012). If this study’s estimate of 50.2% for recent
transmission suffers from bias, it is likely biased towards clustering (indicating greater
recent transmission). This is because the study sample was older, and had more
substance abuse than the general TB case population. Further, anecdotally, if there was
any non-random influence for reasons why certain cases might be sent in for genotyping
(and others not) it could be because contact tracers actually already suspected the case
was part of an outbreak or cluster. The extent to which this may have resulted in
sampling bias is unknown. However, even given these assertions, I would conclude that
50% might be an overestimate of recent transmission, there is good analytical reason to
believe South Carolina’s rate of recent transmission is very high. If I calculate a range
of recent transmission based on the entire denominator of 1,346 confirmed cases we
would still have a recent transmission rate of 25.5 % (343/1346) at the lowest; and this
would be assuming no other cases in the state were clustered which is a rather farfetched assumption. In reality, the recent transmission rate likely lies somewhere
between 25.5 to 50.2%. This means that a staggering 1 to 2 out of every four cases of
TB in South Carolina are due to recent transmission. This is quite substantial for a
wealthy First World country with a low incidence of TB overall. Some European and
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U.S. studies observed similar findings. An English study from 1998 showed a 52% rate
of clustering and 40% rate of recent transmission; a national study carried out in the
Netherlands during 1993–1997 found estimates for clustering and recent transmission of
46% and 35%, respectively; and a study of 7 sentinel surveillance sites in the USA
during 1996–2000 estimated clustering at 48%; and a cross-sectional study during
2005–2009 estimated recent transmission as 23%, (Love, 2009; Moonan, 2012; Ellis,
2002; van Soolingen, 1999).
With regard to risk factors for clustering, the results of this study are fairly
consistent with what has been observed in prior U.S. studies. Almost all U.S. studies
have found U.S. birth to be an independent predictor for clustering. US-born persons
would have had more time in the U.S. to have acquired and spread TB to their contacts,
than recently arrived immigrants. Additionally, it does make sense that infected persons
born outside of the U.S. might be more likely to have acquired TB in their country of
origin, as the U.S. has a relatively low incidence of TB compared to much of the
developing world. Further, U.S. physicians may be more likely to recognize TB
symptoms and test for TB in immigrants from the developing world than in native U.S.
persons. Thus, foreign-born persons may be more likely to have a singleton genotype if
their TB is diagnosed early after arrival, whereas U.S. cases may go unrecognized
longer allowing for more spread prior to intervention. To summarize foreign-born
persons are more likely to have acquired their TB natively within a genotype cluster in
their country of origin and may or may not propagate that cluster once they immigrate.
Therefore, this finding is consistent and makes sense.
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Almost all U.S. studies have observed Black race to be independently predictive
of TB clustering and a few European studies have as well (Barnes, 1997; Cattamanchi,
2006; Ellis, 2006; Kempf, 2005; Cacho-Calvo, 2005). Importantly, 63% of the study
population and 59% of South Carolina TB cases overall are of Black race, even though
only about 30% of South Carolina’s population is Black. Because TB disproportionately
affects Black South Carolinians, this finding, while not surprising, is important. It
would appear that in South Carolina, Black people are at much higher risk for TB
transmission than other races. It is difficult to know if the risks Black people face are
due to factors other than race. Because TB is a highly contagious, airborne disease for
which close family contacts would be at risk, certainly, familial clusters will usually
include a racial component as people that are biologically related to each other are
likely to be of the same race. However, the literature indicates the higher risks
experienced by Black people are almost certainly environmental (Kempf, 2005;
Talarico, 2011; Weis, 2002). Recall this study’s final model controlled for some
environmental factors such as substance abuse, homelessness, origin, and a previous TB
diagnosis; and Black race remained highly significant. Some hypotheses that have been
presented in other studies include that southern Black Americans are adverse to the
public health system because of past segregation, institutional racism, and an overall
perception of mistrust (Mays, 2012; Mays, 2017; Wechkunanukul, 2016). This mistrust
perception in people of Black race may result in being reluctant to seek diagnosis and
treatment. Further when diagnosed, people of black race maybe less forthcoming to
public health investigators regarding contacts, and well as contacts might be harder to
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find and follow if they are attempting to avoid the government-based public health
sector.
Unfortunately, this study was not able to access socioeconomic factors that may
also play a role in the increased risk for people of Black race and TB clustering.
Differences in the uninsured populations of Black and whites may certainly effect
access to care and result in treatment and diagnosis delays causing higher rates of TB
transmission, thus clustering. For Black people, the likelihood of being uninsured varies
widely across states, however, uninsured rates for nonelderly Blacks are particularly
high in the South. The uninsured rate for nonelderly Black people in South Carolina is
between 23 and 30% (Duckett, 2013). In the US, Blacks are significantly more likely
than Whites to be uninsured with more than 1 in 5 (21%) nonelderly Blacks uninsured,
compared to 13% of their White counterparts (Duckett, 2013). Future research is needed
to determine the reason or combination of reasons southern Black Americans are
disproportionately affected by TB and how best to address these reasons.
Unlike my study, several U.S. studies have observed either alcohol, drug abuse,
or all substance abuse as independently predictive for clustering. In an Arkansas, study
(Talarico, 2011) rates of clustering were 19.8% among those with a history of alcohol
abuse versus 8.6% among those without (p-value < 0.0001). Moonan’s comprehensive
US-wide study, noted earlier, also found a strong association between clustering and
being more likely to abuse substances with an aOR of 1.4 (99% C.I. 1.3-1.7), where
substance abuse was any abuse of drugs or alcohol (2012). In this study, substance
abuse was significant in the bivariate model, and 33% of clustered cases were alcohol
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abusers compared to only 20% of non-clustered cases. While 18% of clustered cases
were drug, abusers compared to only 10% of non-clustered cases. As discussed earlier,
my study sample was statistically different from the South Carolina case population
with regard to alcohol and drug abuse. Alcoholic and drug addicts were overrepresented
in the study sample, which may explain some of this perceived association; however, it
is not likely to explain all of it. Importantly, recall from Chapter 2 that persons with
substance abuse may be at greater risk for clustering for a number of reasons. They may
(1) congregate closely in social settings such as bars (2) have poor recall of social
contacts and events, thus are not able to provide a comprehensive contact list to public
health investigators delaying or preventing PEP initiation, (2) have unknown, thus
uncontrolled for co-morbidities that increase their vulnerability for disease as well as
decrease the time they progress from infection to disease, or (3) be more prone to
treatment non-adherence due to the interaction of alcohol and common TB drugs, (5)
have poor nutrition and other substance abuse related health issues (6) persons who
abuse alcohol, crack cocaine, heroin, marijuana, and methamphetamines have all been
shown to experience significant weakening to one or more important immunologic
mechanisms (Gamble, 2006; Baldwin, 1997; Lysle, 2000; Tashkin, 2002; Friedman,
2003; Mahajan, 2006) (7) substance abuse occurs in enclosed spaces with intentionally
limited or poor ventilation and high volumes of human traffic likely increasing the odds
of TB transmission (Oeltmann, 2006; Oeltmann, 2009), and (8) previous research has
noted that persons who abuse substances are less likely to seek treatment resulting in an
extended period of infectiousness and advanced disease at diagnosis (CDC, 2003). It
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seems likely that contact tracing in these groups may not be as effective, leading to
ongoing transmission.
In this study there were a few interesting findings that are somewhat inconsistent
compared with prior research. First, current incarceration was not found to be associated
with clustering. Recall that Kempf’s Alabama study observed an aOR of 2.9 (95%
C.I.1.3- 6.6) (2005) for the association of clustering and residence in a correctional
facility in the year prior to diagnosis. However, in contrast, Moonan’s U.S. wide
population-based study did not observe an association with residence in a correctional
facility at the time of diagnosis (aOR 0.8; 99% C.I. 0.7-1.0) (2012). Moonan’s and this
study likely had similar results (contrasting with Alabama’s) regarding incarceration
because our studies assessed only current incarceration, not prior or recent. This might
suggest that the risk of TB transmission in incarceration settings may be more often due
to short term stays in jails where TB often goes undiagnosed and untreated. Then the
inmate is put back on the street to spread TB, where he or she might finally be
diagnosed by the public health surveillance system.
Next, HIV status was not observed to be a significant predictor in my study as it
has in a few prior U.S. studies (Ellis, 1994; Talarico, 2011; Moonan, 2012). This could
be for a number of reasons. First, there were very few HIV positive individuals in my
study population and this, coupled with the fact that there were many individuals in my
study population that had to be dropped from analysis due to unknown HIV status
(recall this was the primary variable which necessitated dropping cases), these low
numbers substantially decreased my power in both the bivariate and multivariate
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analysis to reveal an effect, if, in fact, one exists. Further, it is not inconceivable that
people who refuse HIV testing do so because they have multiple HIV risk factors, or in
fact, already know they are positive and do not share those results. This could have
biased the findings. Also, this study had contained no information regarding immunecompetence of any HIV positive individual. Thus, an HIV positive person that is
receiving HIV therapy with adequate immune-competence may not be at a noticeably
increased risk of being part of a TB cluster.
Limitations of Study
A few limitations should be noted that affect the interpretation of the findings and
the generalizability of my results. First, my study was limited to those confirmed TB
cases for which a valid TB genotype could be obtained. As discussed at length in Chapter
3, generally cases that are exclusively extrapulmonary (those are TB cases that have only
extrapulmonary disease rather than both pulmonary and extrapulmonary) are confirmed
via some other testing methodology such as a PCR instead of culture, thus there is not
culture to genotype. This was true with the exception of extrapulmonary cases that are of
the pleural space of the lungs, which are usually confirmed, similar to pulmonary cases
using sputum specimen cultures. Another reason a case may have been considered
ineligible for culture was the age of the patient. Patients, ages between 5 and 12 years, are
difficult to obtain a positive culture from and cultures are often not attempted or used for
confirmation. Once those confirmed cases considered “ineligible” for genotype were
excluded only 1,080 of the 1,346 TB cases in South Carolina from 2005-2011 were eligible
for genotype. Of these, 685 were successfully genotyped. The other cases were not
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genotyped for a variety of reasons including a culture was not obtained because the patient
was lost to follow-up, the patient had a negative culture but was confirmed via some other
combination of tests or symptoms, or the diagnosing laboratory simply did not send their
TB isolates to the National TB lab for genotyping. Thus, only 50.9% (685/1,346) of all TB
confirmed cases were genotyped. The 49.1% of confirmed incident cases that were not
genotyped may have differed from the 685 incident TB cases in important ways that may
have biased my results. However, I was able to use publically available descriptive data on
the TB incident case population of South Carolina from 2005 to 2011 to compare with my
fully genotyped sample on all the covariates examined in my study. This information was
available through an intranet query site called the CDC’s Online Tuberculosis Information
System (OTIS) that provides data in 5-year aggregate summary totals by state (CDC,
2016). From this, I was able to determine how alike or different my sample was from the
entire sampling frame in at least a few characteristics (see Table 8). In addition, this
limitation also represents an opportunity. There was a high proportion (43%) of TB cases
without a culture, and therefore, not genotyped. This is an opportunity to emphasize the
importance of comprehensive TB case genotyping, in order to fully characterize the
molecular epidemiology of TB in any jurisdiction or geography. This is discussed further
in the Recommendations section of this chapter.
This second limitation of this study was that it was limited in place and time, in
that I am only able to examine genotypes of cases diagnosed within South Carolina
between 2005 and 2011. Cases diagnosed outside of this time period (either before or
after) within South Carolina, cases diagnosed within this time period but outside of
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South Carolina, and cases diagnosed outside this time period (either before or after) and
outside of South Carolina will not be included in this study. This means that TB chains
of transmission beyond the geographic and time boundaries set in this study cannot be
investigated. Certainly, this is a common limitation of all molecular epidemiological
studies, as researchers will always be limited by the data they collect or, as in the case
of this study, that which was secondarily available to them. However, because TB
transmission recognizes no time or geographical boundaries, this will have implications
for the conclusions that may be drawn from study’s findings. These implications are
explored in the Conclusions, Chapter 5, of this research.
A third limitation of this study was that for the purposes of answering Research
Question 1(b) what proportion of TB in South Carolina may be due to recent
transmission?. To answer this question epidemiological information (dates of onset,
diagnosis, etc.) was not reviewed. This determination was a mathematical calculaton in
order to provide a reasonable indication of the proportion of South Carolina TB cases
that may be due to recent transmission. The epidemiological assertion is based on recent
transmission index of (RTI) i.e., RTIn-1 = (nc - c)/n, in which n is the total number of
the studied cases, nc is the total number of cases in cluster (size 2 or greater) and c is the
number of genotypes represented by at least two cases. Based on this index, patients in
cluster are considered as recent transmission and non-cluster cases are considered as
reactivation. This index also has been referred to as the “n - 1 method.” In depth review
of source medical records to determine true source cases for comparison to the
mathematically calculated determination were not the approach of this study for two
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reasons. First, because the time it takes latent TB infection to manifest to disease varies
widely as it was often a result of both known and unknown host factors, dates of onset
and diagnosis obtained may not be helpful or reliable in determing source or index cases
for clusters or outbreaks. Second, most TB population-based molecular epidemiological
studies do not use medial record review to determine the proportion of recent
transmission, but do it mathematically in just the way I have outlined in Research
Question 1(b). This was an exceptible limitation because the methods used in this study
were consistent with previous research making my research comparable to other studies
of this nature.
Recommendations
The findings revealed that a considerable portion of TB in South Carolina was due
to recent transmission, and U.S. birth and Black race were independently and significantly
associated with being part of a TB genotype cluster of two or more cases. While incident
cases of TB have decreased in South Carolina over the previous 8 years, going from 261
cases reported in 2005 to 140 cases reported (South Carolina DHEC, 2014), South
Carolina still had the 15th highest case rate in the U.S. with 3 cases per 100,000 people
(CDC, 2013). TB is a significant public health problem in South Carolina, it is with that
in mind this study was undertook, and recommendations are made. While South
Carolina has a relatively low incidence of TB, in general it does appear that most of
their TB is due to recent transmission, not importation or reactivation; thus happening
well within the purview of the United States’ seemingly robust health care system. This
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indicates that opportunities for prevention and interruption of the chain of transmission
are being missed.
Based on the process and results of this study, I would make several specific
recommendations to the South Carolina TB Control Program.
1. From 2005-2011, 37% of eligible TB cases in South Carolina did not have a
genotyped culture and 49.1% of all TB cases did not have a genotyped culture. The
proportion of cases in South Carolina being genotyped is too low. While it is difficult
to obtain a culture on all TB cases for a variety of reasons (reasons discussed at
length in earlier chapters), every effort should be made at the local and state level to
make this happen. Every TB case should be confirmed with a culture and every
culture should be genotyped, especially children. Understandably, children are
difficult on which to obtain cultures, but they are also the most important. Because
children progress quickly for TB infection to TB disease, they might be sentinel
cases in a TB cluster or outbreak. Further, TB in children is usually an indication of
new and ongoing transmission. Confirming pediatric cases with a culture and
knowing their genotypes early is of the utmost importance. Health department staff
should follow-up with private sector providers and labs to make sure cultures are
sent in for genotyping. There are important reasons to obtain a genotype on every
case that go well beyond having complete research data. They include:
a. identification or confirmation of outbreaks,
b. identification of locations at which transmission occurs,
c. identification of characteristics of TB disseminators,
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d. characteristics of people at increased risk for acquiring TB infection and
for rapid progression to TB,
e. detection of unsuspected transmission,
f. determination of the potential for reinfection,
g. detection of laboratory cross-contamination and
h. evaluation of TB control activities designed to prevent transmission.
2. The TB case record and accompanying RVCT is not a static document, it should be
continuously updated as new information is revealed. While the issue of missing data
was not a problem in this study, it was apparent in data review that some patient
characteristics were much less complete than those examined by this study. For
instance, patient employer/occupation contained many unknown/missing data. In
addition, the question of whether antibiotic susceptibilities were performed, and the
associated results of those susceptibilities also contained a lot of unknown/missing
information. Having more complete case records is important for conducting formal
studies such as this one, as well as evaluating the effectiveness of prevention and
control efforts.
3. In South Carolina, measures should be implemented to address the staggering racial
disparity in TB disease. This will be daunting task, but should begin with a few
initial steps. First, the racial and ethnic makeup of the DHEC TB control staff should
better reflect the TB case population. Additionally, language, ethnic, cultural, and
economic barriers should not be obstacles to prevent thorough case and contact
investigations. Community partners may be enlisted such as churches and
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community health centers. Where there have been other areas of public health
success in addressing racial disparities such as diabetes education, smoking cessation
promotion, and HIV control and prevention, determine if there are opportunities for
TB education to piggyback off some of these efforts.
4. While substance abuse was not significant in the final model, this study revealed that
substance abusers were clustered more than not. Alcohol and drug environments are
likely places where TB is being spread. Drinking and drugging acquaintances should
not be overlooked in contact investigations. Understandably, a cases’ addiction
behavior is a sensitive topic of discussion however, contact tracers should repeatedly
query it.
5. While recent homelessness was only a significant predictor in the crude model,
homeless shelters or camps might also be places where TB is being spread. Street
friends, “couch surfing” contacts, and other transient living environments should be
investigated thoroughly. Homeless adults and unemployed adults stating they have
estranged family or no family should not be assumed to have no contacts.
6. HIV status was not a significant predictor of TB clustering in this study population.
However, HIV status was unknown 8% of these cases. It is important that every TB
case be offered and strongly encouraged to take an HIV test. Further, contacts to
infectious TB cases should be tested for HIV in order to prioritize them for
treatment.
7. Contact investigations must move beyond the traditional approach. Typically, the
South Carolina TB Control Program uses the concentric circle approach to prioritize
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contact investigations. Several studies have shown the concentric circle method often
misses peripheral, yet high risk contacts (Moro, 2002, Izumi, 2015, Feske, 2011,
Driver, 2006). This is probably resulting in contacts and cases being missed.
Alternatives to the traditional contact investigation should be piloted in South
Carolina. This could include social network contact tracing, or activity-spacecontact-tracing.
8. “Lost to follow-up” status is unacceptable for TB cases. Because TB is a highly
infectious and, when untreated, a sometimes-fatal disease, all efforts should be made
to avoid losing any case for follow-up and treatment.
The current study reveals several opportunities for future research. A southeast U.S. study
with better representation among children is needed. More research is needed to flesh out the
relationship between race and genotype clustering. Specifically, studies need to be conducted
to identify the root causes for the racial disparities in TB disease. More research is needed to
better understand if there is a relationship between being HIV positive and being part of a TB
cluster. A study with complete information on co-morbidities such as diabetes, COPD, and
smoking may help present a more complete model for risk of TB clustering as certain comorbidities that increase the risk of disease progression. Studies or pilot programs
investigating alternatives to the traditional contact investigation should be implemented. A
South Carolina study similar to a Tokyo study by Izumi and colleagues whose aim was to
identify possible tuberculosis hotspots using TB genotype clustering statuses and the concept
of "activity space", which is a place where patients spend most of their waking hours might be
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very informative for determining where to target control efforts (Izumi, 2015). Also, a study
using Social Network Analysis might be indicated.
Implications for Social Change
As stated previously, the goal of the research was to estimate the proportion of
South Carolina TB that may be due to recently acquired infection, and determine the risk
factors associated with the genetic clustering of identical M. tuberculosis isolates. The
research performed was able to answer the research questions and provide insight into the
previously unknown transmission dynamics and molecular epidemiology of TB in South
Carolina. The study findings provide opportunities for social change. The
recommendation section above provides useful information for TB services and policy
makers to help identify where resources may be best deployed.
The relationships revealed indicate more could be done to interrupt the TB chain
of transmission at the individual and local level. At the individual level as part of the
positive social change implications of this research it is my hope that cases that would
have been missed when investigated with traditional contact investigation alone, will be
discovered when employing targeted contact investigation informed by the findings of
this study. At the organizational level, genotyping may facilitate quicker confirmation
of known contacts, detection of unknown contacts, or revelation of transmission
environments (Malakmadze, 2006; Yeo, 2006). If a jurisdiction participates in the U.S.
national TB genotyping program, consistently sends all their confirmed case specimens
in for genotyping, and checks those results frequently they may find linked cases that
their standard contact investigations did not reveal. In addition, TB contact tracers may
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confirm suspected epidemiological links they were already investigating. This approach
may help a jurisdiction make decisions about how aggressive and widespread their
contact investigations should or should not be, where to focus limited resources, and if
there are transmission environments traditional contact investigations are missing.
Targeted contact-investigation informed by TB genotype results could result in an
overall cost-savings to the South Carolina TB Control Program and similar programs.
At the societal level, the social change implication is that it might facilitate
reaching the U.S. TB elimination goals by informing the South Carolina TB Control
Program and potentially other states’ control efforts, particularly states with similar
populations and public health resources as that of South Carolina. As discussed in the
recommendations section above, the study’s findings provide a platform for future
research. This research could lead to better TB control efforts that result in an
interruption in the chain of transmission and resulting in fewer TB infections. This
would bring the U.S. one-step closer to TB elimination.
Conclusion
The purpose of this research was to estimate the proportion of South Carolina TB
that may be due to recently acquired infection, and determine the risk factors associated
with the genetic clustering of identical M. tuberculosis isolates. The results indicated that
a considerable portion of TB in South Carolina was due to recent transmission.
Additionally, the results showed U.S. birth and being of Black race were independently
and significantly associated with being part of a TB genotype cluster of two or more
cases. The key messages of this study are (a) a substantial portion of TB in South
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Carolina is due to recent transmission not reactivation or importation, and (b)
transmission of TB in South Carolina occurs in groups often defined by American origin,
and Black race. These important points reveal one important conclusion; most TB in
South Carolina is preventable. Because the global and domestic impact of TB disease is
substantial with global incidence by recent estimates nearly 9.6 million people, and in the
U.S. between 500 and 600 people dying every year from TB (WHO, 2016), TB
elimination is an important public health goal. TB although an ancient plague is now
preventable, treatable, and curable. TB elimination in the developed world is within
reach.
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Appendix B: Analysis Process Tables

Table B1
Full Stepwise Procedure for Final Model Selection for the Relationship between Tuberculosis Genotype
Clustering and Risk Factors
The LOGISTIC
Procedure
Model
Information
Data Set
Response
Variable
Number of
Response Levels
Model
Optimization
Technique
Number of
Observations
Read
Number of
Observations
Used
Response Profile
Ordered
Value
1
2

OUT.TBGENO3
Clustered
2
binary logit
Fisher's scoring

627

627

Clustered
Yes
No

Total
Frequency
382
245

Value
Other
Hispanic/Latino
Black
White

Design
Variables
1
0
0
-1

Probability
modeled is
Clustered='Yes'.
Stepwise
Selection
Procedure
Class Level
Information
Class
Race

0
1
0
-1

0
0
1
-1
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Substance Abuse
Homelessness
Previous TB
Disease
Age
Origin

Yes
No
Yes
No

1
-1
1
-1

Yes
No
Old
Young
US-Born
Foreign-Born

1
-1
1
-1
1
-1

=

839.029

DF
8

Pr > ChiSq
<.0001

Intercept Only
841.029
845.47
839.029

Intercept
and
Covariates
771.455
780.337
767.455

Step 0. Intercept
entered:
Model
Convergence
Status
Convergence
criterion
(GCONV=1E-8)
satisfied.
-2 Log L
Residual ChiSquare Test
Chi-Square
86.5728
Step 1. Effect
Origin entered:
Model
Convergence
Status
Convergence
criterion
(GCONV=1E-8)
satisfied.
Model Fit
Statistics

Criterion
AIC
SC
-2 Log L
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Testing Global
Null Hypothesis:
BETA=0
Test
Likelihood Ratio
Score
Wald
Residual ChiSquare Test
Chi-Square
15.902

Chi-Square
71.5741
72.4848
64.4654

DF
1
1
1

DF
7

Pr > ChiSq
0.026

Intercept Only
841.029
845.47
839.029

Intercept
and
Covariates
768.57
790.775
758.57

Chi-Square
80.4593
80.6662
71.4186

DF
4
4
4

DF

Pr > ChiSq

Pr >
ChiSq
<.0001
<.0001
<.0001

Note: No effects
for the model in
Step 1 are
removed.
Step 2. Effect
Race entered:
Model
Convergence
Status
Convergence
criterion
(GCONV=1E-8)
satisfied.
Model Fit
Statistics

Criterion
AIC
SC
-2 Log L
Testing Global
Null Hypothesis:
BETA=0
Test
Likelihood Ratio
Score
Wald
Residual ChiSquare Test
Chi-Square

Pr >
ChiSq
<.0001
<.0001
<.0001

147
6.7964

4

0.147

Note: No effects
for the model in
Step 2 are
removed.
Note: No
(additional)
effects met the
0.05 significance
level for entry
into the model.
Summary of
Stepwise
Selection

Step
1
2

Effect Entered
Origin
Race

Removed

DF
1
3

Wald
Chi-Square
9.0604
11.9979

Pr >
ChiSq
0.0285
0.0005

Number
In
1
2

Score
ChiSquare
72.485
9.2341

SE
0.114
0.313
0.3098
0.263
0.2505

Wald
ChiSquare
0.8395
1.1974
0.0396
0.56
11.998

Wald
ChiSquare

Type 3 Analysis
of Effects

Effect
Race
Origin

DF
3
1

Analysis of
Maximum
Likelihood Est.s

Parameter
Intercept
Race

Origin

Other
Hispanic/Latino
Black
US-Born

DF
1
1
1
1
1

Odds Ratio
Estimates
95% Wald

Effect

Point Estimate

Confidence
Limits

Est.
-0.1045
0.3425
-0.0617
0.1968
0.8676

Pr >
ChiSq
0.36
0.274
0.842
0.454
5E-04

Pr >
ChiSq
<.0001
0.026
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Race Other vs.
White

2.271

0.764

6.749

Race
Hispanic/Latino
vs. White

1.516

0.514

4.473

Race Black vs.
White

1.963

1.225

3.144

Origin US-Born
vs. Foreign-Born

5.67

2.124

15.136

Percent
Concordant

49.5

Somers' D

0.354

Percent
Discordant
Percent Tied

14.1
36.4

Gamma
Tau-a

0.557
0.169

Pairs

93590

c

0.677

Association of
Predicted
Probabilities and
Observed
Responses

Table B2
All (7) Multivariable Logistic Regression Models including Interaction Terms for the Relationship between
Tuberculosis Genotype Clustering and Covariates of Interest
1. The LOGISTIC
Procedure Testing
the Origin and
Race Interaction
Term.
Model
Information
Data Set
Response Variable
Number of
Response Levels
Model
Optimization
Technique

OUT.TBGENO3
Clustered

2
binary logit
Fisher's scoring

149
Number of
Observations
Read

627

Number of
Observations
Used

627

Response Profile
Ordered
Value
1
2

Clustered
Yes
No

Total
Frequency
382
245

Value
Other

Design
Variables
1

Hispanic/Latino
Black
White
US-Born

0
0
-1
1

Foreign-Born

-1

Probability
modeled is
Clustered='Yes'.
Class Level
Information
Class
Race

Origin

Model
Convergence
Status

Quasi-complete
separation of data
points detected.
Warning: The
maximum
likelihood
estimate may not
exist.

0

0

1
0
-1

0
1
-1

150
Warning: The
LOGISTIC
procedure
continues in spite
of the above
warning. Results
shown are based
on the last
maximum
likelihood
iteration. Validity
of the model fit is
questionable.
Model Fit
Statistics

Criterion
AIC
SC
-2 Log L

Intercept Only
841.029
845.47
839.029

Intercept and
Covariates
766.743
802.271
750.743

Chi-Square

DF

Pr >
ChiSq

88.2858
85.8964
66.4608

7
7
7

<.001
<.001
<.001

DF
3
1
3

Wald
Chi-Square
2.727
0.003
1.4567

Pr >
ChiSq
0.4357
0.9564
0.6923

Testing Global
Null Hypothesis:
BETA=0
Test
Likelihood Ratio
Score
Wald
Joint Tests
Effect
Race
Origin
Race*Origin
Analysis of
Maximum
Likelihood
Estimates

Parameter
Intercept
Race

DF

Other

1
1

Est.
3.30
3.53

Standard
Error

Wald
ChiSquare

Pr >
ChiSq

68.198
68.199

0.0023
0.0027

0.961
0.958
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Race

Hispanic/Latino

1

Race
Origin
Race*Origin

Black
US-Born
Other

Race*Origin
Race*Origin
Association of
Predicted
Probabilities and
Observed
Responses
Percent
Concordant
Percent
Discordant
Percent Tied
Pairs

68.199

0.0013

0.970

US-Born

1
1
1

2.50
2.85
3.72
2.86

152.5
68.198
68.199

0.0004
0.003
0.0018

0.985
0.956
0.9665

Hispanic/Latino
Black

US-Born
US-Born

1
1

3.62
3.40

68.199
152.5

0.0028
0.0005

0.957
0.982

49.7

Somers' D

0.359

13.8
36.4
93590

Gamma
Tau-a
c

0.565
0.171
0.679

2. The LOGISTIC
Procedure Testing
the Origin and
Previous TB
Disease
Interaction Term.
Model
Information
Data Set
Response Variable
Number of
Response Levels
Model
Optimization
Technique

OUT.TBGENO3
Clustered

2
binary logit
Fisher's scoring

Number of
Observations
Read

627

Number of
Observations
Used

627
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Response Profile
Ordered
Value
1
2

Clustered
Yes
No

Total
Frequency
382
245

Value
US-Born

Design
Variables
1

Foreign-Born
Other

-1
1

0

0

Hispanic/Latino
Black
White

0
0
-1

1
0
-1

0
1
-1

Yes
No

1
-1

Intercept Only
841.029
845.47
839.029

Intercept and
Covariates
768.721
799.808
754.721

Chi-Square

DF

Probability
modeled is
Clustered='Yes'.
Class Level
Information
Class
Origin

Race

Previous TB
Diagnosis
Model
Convergence
Status
Convergence
criterion
(GCONV=1E-8)
satisfied.
Model Fit
Statistics

Criterion
AIC
SC
-2 Log L
Testing Global
Null Hypothesis:
BETA=0
Test

Pr >
ChiSq

153

Likelihood Ratio
Score
Wald
Joint Tests
Effect
Origin
Race
Previous TB
Diagnosis
Origin*Previous
TB Diagnosis

84.3077
83.7743
73.3824

6
6
6

<.001
<.001
<.001

DF
1
3

Wald
Chi-Square
6.7536
8.5973

Pr >
ChiSq
0.009
0.035

1

2.8822

0.089

1

0.0238

0.877

Analysis of
Maximum
Likelihood
Estimates

Parameter
Intercept
Origin
Race
Race
Race
Previous TB
Diagnosis
Origin*Previous
TB Diagnosis
Odds Ratio
Estimates

Effect
Race Other vs.
White
Race
Hispanic/Latino
vs. White
Race Black vs.
White

US-Born
Other

DF
1
1
1

Est.
0.30
0.91
0.32

SE
0.266
0.3536
0.3146

Wald
ChiSquare
1.3287
6.7536
1.0498

Hispanic/Latino
Black

1
1

0.03
0.19

0.3111
0.2632

0.0133
0.5248

0.908
0.468

Yes

1

0.45

0.2651

2.8822

0.089

1

0.04

0.2653

0.0238

0.877

US-Born

Yes

Point Estimate

95% Wald
Confidence
Limits

2.224

0.746

6.632

1.555

0.526

4.598

1.95

1.215

3.128

P>
ChiSq
0.249
0.009
0.305
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Association of
Predicted
Probabilities and
Observed
Responses
Percent
Concordant
Percent
Discordant
Percent Tied
Pairs

51.5

Somers' D

0.367

14.8
33.8
93590

Gamma
Tau-a
c

0.554
0.175
0.683

3. The LOGISTIC
Procedure Testing
the Origin and
Substance Abuse
Interaction Term.
Model
Information
Data Set
Response Variable
Number of
Response Levels
Model
Optimization
Technique

OUT.TBGENO3
Clustered

2
binary logit
Fisher's scoring

Number of
Observations
Read

627

Number of
Observations
Used

627

Response Profile
Ordered
Value
1
2

Clustered
Yes
No

Total
Frequency
382
245
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Probability
modeled is
Clustered='Yes'.
Class Level
Information
Class
Origin

Race

Substance Abuse
Model
Convergence
Status

Quasi-complete
separation of data
points detected.
Warning: The
maximum
likelihood
estimate may not
exist.
Warning: The
LOGISTIC
procedure
continues in spite
of the above
warning. Results
shown are based
on the last
maximum
likelihood
iteration. Validity
of the model fit is
questionable.
Model Fit
Statistics

Value
US-Born

Design
Variables
1

Foreign-Born
Other

-1
1

0

0

Hispanic/Latino
Black
White

0
0
-1

1
0
-1

0
1
-1

Yes
No

1
-1

156

Criterion
AIC
SC
-2 Log L

Intercept Only
841.029
845.47
839.029

Intercept and
Covariates
769.954
801.041
755.954

Chi-Square

DF

Pr >
ChiSq

83.0747
82.6179
71.8622

6
6
6

<.001
<.001
<.001

DF
1

Wald
Chi-Square
0.001

Pr >
ChiSq
0.974

1
3

0.0005
8.3197

0.981
0.039

1

0.0006

0.980

Testing Global
Null Hypothesis:
BETA=0
Test
Likelihood Ratio
Score
Wald
Joint Tests
Effect
Origin
Substance Abuse
Race
Origin*Substance
Abuse
Analysis of
Maximum
Likelihood
Estimates

Parameter
Intercept
Origin
Substance Abuse
Race
Race
Race
Origin*Substance
Abuse
Odds Ratio
Estimates

DF

SE

Wald
ChiSquare

117
117

0.0006
0.001

0.980
0.974

Pr >
ChiSq

US-Born

1
1

Est.
2.84
3.77

Yes
Other

1
1

2.71
0.35

117
0.3129

0.0005
1.2741

0.981
0.259

Hispanic/Latino
Black

1
1

0.03
0.16

0.3102
0.2638

0.0137
0.3886

0.9067
0.533

1

2.92

117

0.0006

0.980

US-Born

Yes
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Effect
Race Other vs.
White
Race
Hispanic/Latino
vs. White
Race Black vs.
White
Association of
Predicted
Probabilities and
Observed
Responses
Percent
Concordant
Percent
Discordant
Percent Tied
Pairs

Point Estimate

95% Wald
Confidence
Limits

2.303

0.775

6.845

1.56

0.528

4.608

1.907

1.188

3.062

54.9

Somers' D

0.37

17.9
27.2
93590

Gamma
Tau-a
c

0.508
0.176
0.685

4. The LOGISTIC
Procedure Testing
the Origin and
HIV Status
Interaction Term.
Model
Information
Data Set
Response Variable
Number of
Response Levels
Model
Optimization
Technique

OUT.TBGENO3
Clustered

2
binary logit
Fisher's scoring

Number of
Observations
Read

627

Number of
Observations
Used

627
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Response Profile
Ordered
Value
1
2

Clustered
Yes
No

Total
Frequency
382
245

Value
US-Born

Design
Variables
1

Foreign-Born
Other

-1
1

Hispanic/Latino
Black
White
Yes
No

0
0
-1
1
-1

Intercept Only
841.029
845.47
839.029

Intercept and
Covariates
772.388
803.475
758.388

Chi-Square

DF

Probability
modeled is
Clustered='Yes'.
Class Level
Information
Class
Origin

Race

HIV Status

0

0

1
0
-1

0
1
-1

Model
Convergence
Status
Convergence
criterion
(GCONV=1E-8)
satisfied.
Model Fit
Statistics

Criterion
AIC
SC
-2 Log L
Testing Global
Null Hypothesis:
BETA=0
Test

Pr >
ChiSq

159

Likelihood Ratio
Score
Wald
Joint Tests
Effect
Origin
HIV Status
Race
Origin*HIV
Status

80.6409
80.8195
71.536

6
6
6

<.000
<.000
<.000

DF
1
1
3

Wald
Chi-Square
7.6033
0.0589
8.8275

Pr >
ChiSq
0.005
0.808
0.031

1

0.0033

0.954

Analysis of
Maximum
Likelihood
Estimates

Parameter
Intercept
Origin
HIV Status
Race
Race
Race
Origin*HIV
Status
Odds Ratio
Estimates

Effect
Race Other vs.
White
Race
Hispanic/Latino
vs. White
Race Black vs.
White
Association of
Predicted
Probabilities and
Observed
Responses

US-Born
Yes
Other

DF
1
1
1
1

Hispanic/Latino
Black

1
1

Est.
0.05
0.87
0.05
0.34
0.06
0.19

1

0.01

US-Born

Yes

Point Estimate

95% Wald
Confidence
Limits

2.276

0.761

6.805

1.507

0.51

4.45

1.945

1.212

3.121

SE
0.2409
0.3187
0.2346
0.3161

Wald
ChiSquare
0.0516
7.6033
0.0589
1.2119

0.3103
0.2638

0.043
0.5232

0.835
0.469

0.2339

0.0033

0.954

Pr >
ChiSq
0.820
0.005
0.808
0.271
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Percent
Concordant
Percent
Discordant
Percent Tied
Pairs

53.2

Somers' D

0.363

17
29.8
93590

Gamma
Tau-a
c

0.517
0.173
0.681

5. The LOGISTIC
Procedure Testing
the Previous TB
Diagnosis and
Race Interaction
Term.
Model
Information
Data Set
Response Variable
Number of
Response Levels
Model
Optimization
Technique

OUT.TBGENO3
Clustered

2
binary logit
Fisher's scoring

Number of
Observations
Read

627

Number of
Observations
Used

627

Response Profile
Ordered
Value
1
2

Clustered
Yes
No

Total
Frequency
382
245

Value
US-Born

Design
Variables
1

Probability
modeled is
Clustered='Yes'.
Class Level
Information
Class
Origin

161

Previous TB
Diagnosis
Race

Foreign-Born

-1

Yes
No
Other

1
-1
1

0

0

Hispanic/Latino
Black
White

0
0
-1

1
0
-1

0
1
-1

Intercept Only
841.029
845.47
839.029

Intercept and
Covariates
772.43
812.398
754.43

Chi-Square

DF

Pr >
ChiSq

84.5996
83.8672
73.1044

8
8
8

<.001
<.001
<.001

DF
3
1

Wald
Chi-Square
2.0279
12.1922

Pr >
ChiSq
0.566
0.001

1

2.1003

0.147

3

0.3187

0.956

Model
Convergence
Status
Convergence
criterion
(GCONV=1E-8)
satisfied.
Model Fit
Statistics

Criterion
AIC
SC
-2 Log L
Testing Global
Null Hypothesis:
BETA=0
Test
Likelihood Ratio
Score
Wald
Joint Tests
Effect
Race
Origin
Previous TB
Diagnosis
Previous TB
Diagnosis*Race

162
Analysis of
Maximum
Likelihood
Estimates

Parameter
Intercept
Race
Race
Race
Origin
Previous TB
Diagnosis

Other

DF
1
1

Est.
0.27
0.25

SE
0.2873
0.5204

Wald
ChiSquare
0.9274
0.2441

Hispanic/Latino
Black
US-Born

1
1
1

0.06
0.34
0.87

0.6315
0.4589
0.2514

0.0119
0.5673
12.192

0.913
0.451
0.000

Yes

1

0.41

0.2873

2.1003

0.147

Pr >
ChiSq
0.335
0.621

Previous TB
Diagnosis*Race

Yes

Other

1

0.07

0.4685

0.0239

0.877

Previous TB
Diagnosis*Race

Yes

Hispanic/Latino

1

0.11

0.5833

0.0394

0.842

Yes

Black

1

0.16

0.3932

0.1714

0.678

Point Estimate

95% Wald
Confidence
Limits

5.788

2.16

15.50

51.5

Somers' D

0.368

14.7
33.8
93590

Gamma
Tau-a
c

0.556
0.176
0.684

Previous TB
Diagnosis*Race
Odds Ratio
Estimates

Effect
Origin US-Born
vs. Foreign-Born
Association of
Predicted
Probabilities and
Observed
Responses
Percent
Concordant
Percent
Discordant
Percent Tied
Pairs
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6. The LOGISTIC
Procedure Testing
the Substance
Abuse and Race
Interaction Term.
Model
Information
Data Set
Response Variable
Number of
Response Levels
Model
Optimization
Technique

OUT.TBGENO3
Clustered

2
binary logit
Fisher's scoring

Number of
Observations
Read

627

Number of
Observations
Used

627

Response Profile
Ordered
Value
1
2

Clustered
Yes
No

Total
Frequency
382
245

Value

Design
Variables

Yes
No
US-Born

1
-1
1

Foreign-Born
Other

-1
1

0

0

Hispanic/Latino

0

1

0

Probability
modeled is
Clustered='Yes'.
Class Level
Information
Class
Substance Abuse
Origin

Race

164
Black
White

0
-1

0
-1

Intercept Only
841.029
845.47
839.029

Intercept and
Covariates
771.567
807.095
755.567

Chi-Square

DF

Pr >
ChiSq

83.462
83.0868
72.3752

7
7
7

<.001
<.001
<.001

Model
Convergence
Status

Quasi-complete
separation of data
points detected.
Warning: The
maximum
likelihood
estimate may not
exist.
Warning: The
LOGISTIC
procedure
continues in spite
of the above
warning. Results
shown are based
on the last
maximum
likelihood
iteration. Validity
of the model fit is
questionable.
Model Fit
Statistics

Criterion
AIC
SC
-2 Log L
Testing Global
Null Hypothesis:
BETA=0
Test
Likelihood Ratio
Score
Wald
Joint Tests

1
-1

165

Effect
Substance Abuse
Origin
Race
Substance
Abuse*Race

Substance Abuse
Yes Race Black =

DF

Wald
Chi-Square

Pr >
ChiSq

1
1
3

1.1265
11.5907
1.2116

0.288
0.001
0.750

2
Intercept +
Substance Abuse
Yes + 3 * Race
Other - Race
Hispanic/Latino
- Race Black + 3
* Substance
Abuse Yes Race
Other Substance Abuse
Yes Race
Hispanic/Latino

0.3685

0.832

Analysis of
Maximum
Likelihood
Estimates

DF
1

Est.
0.03

SE
0.1871

Wald
ChiSquare
0.0415

Yes
US-Born
Other

1
1
1

0.16
0.85
5.39

0.1587
0.2508
141.9

1.1265
11.590
0.0014

0.288
0.000
0.969

Hispanic/Latino
Black

1
1

5.34
0.18

141.9
0.2655

0.0014
0.474

0.97
0.491

141.9

0.0013

0.971

141.9

0.0014

0.970

Parameter
Intercept
Substance Abuse
Origin
Race
Race
Race
Substance
Abuse*Race
Substance
Abuse*Race
Substance
Abuse*Race
Odds Ratio
Estimates

Effect

Yes

Other

1

Yes

Hispanic/Latino

1

5.03
5.30

Yes

Black

0

0

Point Estimate

95% Wald
Confidence
Limits

Pr >
ChiSq
0.838
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Origin US-Born
vs. Foreign-Born
Association of
Predicted
Probabilities and
Observed
Responses
Percent
Concordant
Percent
Discordant
Percent Tied
Pairs

5.516

2.064

14.74

55

Somers' D

0.372

17.8
27.2
93590

Gamma
Tau-a
c

0.512
0.177
0.686

7. The LOGISTIC
Procedure Testing
the Race and HIV
Status Interaction
Term.
Model
Information
Data Set
Response Variable
Number of
Response Levels
Model
Optimization
Technique

OUT.TBGENO3
Clustered

2
binary logit
Fisher's scoring

Number of
Observations
Read

627

Number of
Observations
Used

627

Response Profile
Ordered
Value
1
2

Clustered
Yes
No

Total
Frequency
382
245
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Probability
modeled is
Clustered='Yes'.
Class Level
Information
Class
Origin

Race

HIV Status

Value
US-Born

Design
Variables
1

Foreign-Born
Other

-1
1

Hispanic/Latino
Black
White
Yes
No

0
0
-1
1
-1

Intercept Only
841.029
845.47
839.029

Intercept and
Covariates
773.988
809.515
757.988

Chi-Square

DF

Pr >
ChiSq

81.0412
81.1609
71.8016

7
7
7

<.001
<.001
<.001

DF

Wald
Chi-Square

Pr >
ChiSq

0

0

1
0
-1

0
1
-1

Model
Convergence
Status
Convergence
criterion
(GCONV=1E-8)
satisfied.
Model Fit
Statistics

Criterion
AIC
SC
-2 Log L
Testing Global
Null Hypothesis:
BETA=0
Test
Likelihood Ratio
Score
Wald
Joint Tests
Effect

168
Origin
Race
HIV Status

1
3
1

12.1509
3.066
0.4352

0.000
0.381
0.509

Race*HIV Status

2

0.3986

0.819

Race Black HIV
Status Yes =

Intercept + 3 *
Race Other Race
Hispanic/Latino
- Race Black +
HIV Status Yes
+ 3 * Race Other
HIV Status Yes Race
Hispanic/Latino
HIV Status Yes

Analysis of
Maximum
Likelihood
Estimates

Parameter
Intercept
Origin
Race
Race
Race
HIV Status

US-Born
Other

DF
1
1
1

Hispanic/Latino
Black
Yes

1
1
1

Est.
0.01
0.87
0.84
0.26
0.16
0.12

SE
0.2098
0.2512
0.8407

Wald
ChiSquare
0.007
12.150
1.0024

0.528
0.2677
0.185

0.2435
0.3682
0.4352

0.621
0.544
0.509

0.7813

0.3984

0.527

0.4951

0.2

0.654

Race*HIV Status

Other

Yes

1

Race*HIV Status

Hispanic/Latino

Yes

1

0.49
0.22

Race*HIV Status
Odds Ratio
Estimates

Black

Yes

0

0

Point Estimate

95% Wald
Confidence
Limits

5.762

2.152

Effect
Origin US-Born
vs. Foreign-Born

15.42

Pr >
ChiSq
0.933
0.000
0.316
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Association of
Predicted
Probabilities and
Observed
Responses
Percent
Concordant
Percent
Discordant
Percent Tied
Pairs

53.2

Somers' D

0.363

17
29.8
93590

Gamma
Tau-a
c

0.517
0.173
0.681

